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Abstract 
 
The two Pseudoalteromonas species P. aurantia NCIMB 2052T, P. citrea 
NCIMB 1889T and the marine filamentous cyanobacterial strain Flo1 have been 
known for the production of inhibitory substances for many years, but the character 
and the mode of action of these substances remained uncovered. Hence, in the 
present study the inhibitory substances of P. aurantia and P. citrea were investigated 
with respect to their substantial and functional nature, their inhibitory potential, their 
stability against various treatments as well as the growth phases and incubation 
conditions when the substances are produced. In addition, an inhibitory substance 
produced by strain Flo1 was examined regarding its structure, function, and 
inhibitory potential. Furthermore, its taxonomic position amongst closely related 
cyanobacteria was investigated by re-constructing phylogenetic trees, showing that 
strain Flo1 is most closely related to the genus Geitlerinema. 
For the inhibitory substances from P. aurantia and P. citrea it could be revealed that 
they strongly inhibit growth of methicillin-resistant Staphylococcus aureus (MRSA), 
Staphylococcus epidermidis, and of several other bacterial strains. Escherichia coli 
UM255, a catalase negative mutant, was the best inhibited organism. Growth of the 
yeast Saccharomyces pastorianus was only partially inhibited by the substances 
from P. aurantia, but not by those from P. citrea, whereas Bacillus subtilis was not 
inhibited at all. Nearly the same results could be obtained for an inhibitory substance 
from Geitlerinema strain Flo1. 
The inhibitor production by P. aurantia and P. citrea could be detected under 
standard incubation conditions during the late exponential to stationary growth 
phase, respectively. When incubated at 10°C, P. citrea produced inhibitory 
substances, whereas P. aurantia did not. The enzymes catalase, peroxidase, and 
proteinase K were neutralising the antibacterial activity of the inhibitory substances 
from both species, whereas -amylase and trypsin did not. Thermolability and 
resistance of the inhibitory substances of both Pseudoalteromonads to acid-alkaline 
treatment could be shown. Isoelectric points of the inhibitors from P. aurantia and 
P. citrea were determined, at pH 8.7 respectively 8.9 and 9.4. 
It could be investigated that the inhibitory substances of both Pseudoalteromonads 
and of Geitlerinema strain Flo1 are amino acid oxidases. In this context it could be 
revealed that the amino acid oxidases from P. aurantia and P. citrea have relatively 
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broad substrate spectra, whereas the amino acid oxidase from strain Flo1 is 
restricted to L-lysine as only substrate. D-amino acids tested could not be used as 
substrates by the different amino acid oxidases under investigation, revealing that 
they are all L-amino acid oxidases (L-AAOs). The L-AAO from strain Flo1 only 
enzymatical converted L-lysine by its activity, concluding that it is a specific L-lysine 
oxidase.  
A practicable and simple method for in-gel detection of L-AAOs after non-denaturing 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) based on 
the visualisation of occurring hydrogen peroxide production was successfully 
developed for the first time to determine their approximate molecular weights and 
number. Non-denaturing SDS-PAGE could be used due to the finding that the 
activity of the inhibitory substances had shown to be relatively resistant to SDS as 
well as ß-mercaptoethanol. Using the newly developed application, it could be 
determined that P. aurantia is most probably producing three L-AAOs (60-65, 
225-230, and >260 kilodalton; kDa), whereas P. citrea is producing only two 
(165-170 and 225-230 kDa). The three inhibitory substances from P. aurantia may all 
be composed of one structural unit of 60-65 kDa in size. Geitlerinema strain Flo1 
formed only one specific ~55 kDa L-AAO. 
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Zusammenfassung 
 
Die beiden Pseudoalteromonas-Arten P. aurantia NCIMB 2052T und P. citrea 
NCIMB 1889T als auch der marine cyanobakterielle Stamm Flo1 sind seit vielen 
Jahren für die Produktion von Hemmstoffen bekannt, allerdings wurden diese 
Substanzen nie genau charakterisiert und auch deren Wirkmechanismus wurde nicht 
hinreichend untersucht. Aus diesen Gründen wurden die Hemmstoffe beider 
Pseudoalteromonaden in der vorliegenden Arbeit hinsichtlich ihrer substanziellen 
sowie funktionellen Natur, ihres inhibitorischen Potentials und ihrer Stabilität 
gegenüber verschiedenen Behandlungsweisen charakterisiert. Zusätzlich wurde 
untersucht, in welchen Wachstumsphasen und unter welchen 
Inkubationsbedingungen die Hemmstoffe produziert werden. Weiterhin wurde auch 
eine Charakterisierung eines Hemmstoffs von Stamm Flo1 bezüglich seiner 
Substanz und Funktion wie auch seines Hemmpotentials vorgenommen. Auch 
wurde die taxonomische Stellung von Stamm Flo1 unter nahe verwandten 
Cyanobakterien mittels der Erstellung von phylogenetischen Stammbäumen 
bestimmt, wodurch gezeigt wurde, dass die nächstverwandten Arten von Flo1 zur 
Gattung Geitlerinema gehören.  
Es konnte festgestellt werden, dass die inhibitorischen Substanzen von P. aurantia 
und P. citrea das Wachstum eines Methicillin-resistenten Staphylococcus aureus 
(MRSA) sowie von Staphylococcus epidermidis und das von verschiedenen anderen 
bakteriellen Stämmen hemmen. Escherichia coli UM255, eine Katalase-negative 
Mutante, wurde am meisten an ihrem Wachstum gehindert, wohingegen das von der 
Hefe Saccharomyces pastorianus nur durch die Substanzen von P. aurantia inhibiert 
wurde, aber nicht durch die von P. citrea. Das Wachstum von Bacillus subtilis wurde 
in keinem der Fälle eingeschränkt. Annähernd die gleichen Ergebnisse konnten für 
den von Stamm Flo1 produzierten Hemmstoff erzielt werden, mit der Ausnahme, 
dass der Einfluss auf MRSA nicht getestet wurde.     
Die Ergebnisse zeigten weiterhin, dass P. aurantia und P. citrea ihre Hemmstoffe 
während der späten exponentiellen bzw. der stationären Wachstumsphase 
produzierten. Bei einer Inkubationstemperatur von 10°C produzierte P. citrea 
Hemmstoffe, P. aurantia hingegen nicht. Die Enzyme Katalase, Peroxidase und 
Proteinase K hoben die antibakterielle Wirkung der inhibitorischen Substanzen 
beider Pseudoalteromonaden auf, wohingegen -Amylase und Trypsin dies nicht 
                                                                                                        Zusammenfassung 
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vermochten. Es konnte festgestellt werden, dass die Hemmstoffe beider Arten 
hitzeempfindlich und in einem weiten pH-Wert-Bereich noch aktiv sind. Weiterhin 
wurden die isoelektrischen Punkte der Hemmstoffe bei pH-Werten von 8.7 bzw. 8.9 
und 9.4 bestimmt.  
Es konnte außerdem gezeigt werden, dass die inhibitorischen Substanzen beider 
Pseudoalteromonaden, ebenso wie die von Geitlerinema Stamm Flo1 produzierte 
Substanz, Aminosäureoxidasen sind. Weitere Untersuchungen zeigten, dass die 
Aminosäureoxidasen von P. aurantia und P. citrea relativ breite Substratspektra 
aufweisen, die Aminosäureoxidase von Stamm Flo1 hingegen ein sehr spezifisches. 
Wenn D-Aminosäuren als Substrate angeboten wurden, konnten diese von keiner 
der untersuchten Aminosäureoxidasen genutzt werden, woraus geschlossen werden 
konnte, dass es sich bei allen Inhibitoren um L-Aminosäureoxidasen handelt. Die 
von Stamm Flo1 produzierte L-AAO konnte nur L-Lysin enzymatisch umwandeln, 
was für eine spezifische L-Lysinoxidase spricht.  
Um die ungefähren Molekulargewichte und die jeweilige Anzahl an L-AAOs 
bestimmen zu können, wurde eine einfache sowie praktikable Methode zur Detektion 
dieser Enzyme nach nicht-denaturierender Natriumdodecylsulfat-
Polyacrylamidgelelektrophorese (SDS-PAGE) entwickelt, basierend auf der 
Visualisierung aufkommender Wasserstoffperoxidproduktion. Dadurch konnten die 
L-AAOs direkt im Polyacrylamidgel detektiert werden. Die genannte Methode konnte 
verwendet werden, da die Hemmstoffe relativ resistent gegen SDS und 
ß-Mercaptoethanol sind. So konnte ermittelt werden, dass P. aurantia 
höchstwahrscheinlich drei L-AAOs mit Molekulargewichten von 60-65, 225-230 und 
>260 Kilodalton produziert, wohingegen P. citrea nur zwei von 165-170 und 
225-230 kDa bildet. Es konnten Hinweise erzielt werden, dass die drei Hemmstoffe 
von P. aurantia aus nur einer strukturellen Grundeinheit von jeweils 60-65 kDa 
aufgebaut sind. Weiterhin konnte ermittelt werden, dass die von Geitlerinema Stamm 
Flo1 produzierte L-AAO ein Molekulargewicht von ~55 kDa aufweist. 
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1. Introduction 
 
1.1 Antibiotics 
 
The word “antibiotic" (from the  - anti, "against", and  - bios, "life") was 
originally defined by Selman A. Waksman as "inhibiting the growth or the metabolic 
activities of bacteria and other micro-organisms by a chemical substance of microbial 
origin" (Waksman, 1947). Nowadays, the term “antibiotic” generally describes any 
compound that kills or inhibits the growth of microorganisms, such as bacteria, fungi, 
and protozoa, while causing no (or less) harm to the host (Madigan et al., 2009).  
 
Antibiotic substances which act against bacteria can be divided into 13 classes, 
whereof ten are dissipated from a natural product template: The molecular structures 
of the aminoglycosides (streptomycin), ß-lactams (penicillins, cephalosporins, 
carbapenems, monobactams), glycopeptides (vancomycin), macrolides 
(erythromycin), phenylpropanoids (chloramphenicol), pleuromutilins (tiamulin and 
valnemulin), polyketides (tetracycline), streptogramins (pristinamycin), and, most 
recently, the glycylcyclines (tigecycline), lipopeptides (daptomycin) as well as 
another pleuromutilin (retapamulin) (Holzmann et al., 1984; Stipkovits et al., 2005; 
Yan et al., 2006; Hughes and Fenical, 2010). The other three classes, the 
quinolones (ciprofloxacin), oxazolidinones (linezolid), and sulfonamides, have no 
prototype in nature (Hughes and Fenical, 2010). In addition, a type of enzymes, the 
L-amino amino acid oxidases (L-AAOs), for example, have antibacterial properties 
also (see chapter 1.3, pages 22-24). 
 
Antibiotics are produced by a diverse group of living beings, namely algae, animals 
(e.g. amphibians, arthropods, molluscs, reptiles, and tunicates), lichens, 
microorganisms (bacteria, fungi), and plants (Gräfe, 1992) and are known to be 
intermediates (Bu'Lock, 1961; Haslam, 1995), waste or end products of the 
metabolism (Vining et al., 1990; Demain and Fang, 2000) as well as other 
substances with antibiotic characteristics (Vallon et al., 1993; Chen et al., 2010b). 
The application of antibiotic substances in medical therapy as a standard practice 
was a milestone in the struggle against several threatening diseases, such as 
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endocarditis, gonorrhea, meningitis, pneumonia, septicaemia as well as tuberculosis 
(Noone, 1978; Grüneberg et al., 1984; Katz et al., 1992). Most common fields of 
applications for antibiotics are the human and veterinary medicine as well as the 
agriculture (Gräfe, 1992). Over two thirds of the clinically used antibiotics have been 
discovered from natural sources or are semi-synthetic derivatives of natural 
substances (Newman and Cragg, 2007), most of them derived from organisms living 
in a terrestrial environment (Okami, 1982). Recently, marine environments were 
coming more and more into focus also, especially marine actinomycete bacteria 
seem to be a promising source for new antibiotics (Bull and Stach, 2007; Bredholt 
et al., 2008). 
 
Antibiotics are not only highly praised health-bringing agents, which humans can use 
for their purposes, they are also problematic. Thus, due to the extensive use and 
misuse of antibiotics in human and veterinary medicine as well as in agriculture, an 
increasing number of resistance mechanisms used by pathogenic bacteria against 
these substances can be noticed (Tait-Kamradt et al., 2000; Tenover, 2006; 
Kumarasamy et al., 2010; Vashishtha, 2010). Unfortunately, this is not directly 
followed by the discovery and development of new and effective antibiotic 
substances (Nathan, 2004). Thereby, it should be kept in mind that the time and 
costs in developing a new antibiotic, from discovery to clinical usage, averages 10-
15 years respectively $800 million (Bragonzi, 2010). Since the early 1960s, just four 
new classes of antibiotics have found their way into use, so the approximately $30 
billion global market for these substances - each year around 500 metric tons are 
produced (Madigan et al., 2009) - is still dominated by antibiotic classes discovered 
half a century ago (Fischbach and Walsh, 2009; see also page 12, Figure 1.1 A 
and B).  
 
Staphylococcus aureus and, in particular, the methicillin-resistant S. aureus (MRSA) 
is a species, with a high pathogenic potential (Naimi et al., 2003; Fridkin et al., 2005). 
The organism is a Gram-positive spherical bacterium, frequently occurring as cell 
clusters, which was first identified as a nosocomial pathogen in the 1960s (Barrett 
et al., 1968). S. aureus is able to expeditiously mutate to gain resistance against 
several antibacterial agents (Schaaff et al., 2002) and, thus, is strongly resistant to 
commercially available antibiotics: Various investigations have identified not only 
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methicillin-resistant, but also vancomycin-resistant (Smith et al., 1999; Tenover et al., 
2004) and teicoplanin-resistant S. aureus strains (Mainardi et al., 1995). 
 
Sulfa drugs
ß-lactams
Chloramphenicol, Tetracyclines
Aminoglycosides
Glycopeptides
Macrolides
Quinolones, Streptogramins
Pseudomutilins
Lipopeptides
Oxazolidinones
Innovation gap
1940 1950 1960 1970 1980 1990 2000 2010
 
 
Fig. 1.1 A: Distribution of the annual global antibiotic production on the different agent 
classes (modified after Madigan et al., 2009). B: Time scale showing the distribution of the 
introduction of important antimicrobial chemotherapeutic agents with an innovation gap 
between 1962 and 2000 (modified after Fischbach and Walsh, 2009). 
 
MRSA strains are known to be one of the main lethal causes among hospital-
acquired infectious diseases (Fridkin et al., 2005). Over the last decades, MRSA 
infections have become endemic in hospitals all over the world (Diekema et al., 
2001), affecting, with rare exception, only patients with established risk factors 
(Brumfitt and Hamilton-Miller, 1989). These risk factors include dialysis, indwelling 
percutaneous medical devices and catheters, recent hospitalization or surgery as 
well as residence in a longterm care facility (Lowy, 1998). More recently, however, 
cases of MRSA have been described among healthy community-dwelling individuals 
without established risk factors for MRSA acquisition (Gorak et al., 1999; Baggett 
et al., 2003; Naimi et al., 2003).  
 
To account for all these facts, antibiotic-resistant S. aureus strains and other clinical 
relevant pathogenic microorganisms are becoming more and more a threatening 
global health care problem and, thus, effective therapeutic agents against these 
organisms are needed urgently.  
 
 
 
 
A B
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1.2 Marine antibiotic-producing microorganisms 
 
As already mentioned in chapter 1.1, marine microorganisms and their potential to 
produce antibiotics are coming increasingly into the focus of scientific research 
worldwide. But these organisms are not only a promising source for antibiotic 
substances, also other microbe-derived bioactive substances with various properties 
were already found and countless more are still waiting to be discovered. 
In the following two chapters (1.2.1 and 1.2.2, pages 19-22), the genera 
Pseudoalteromonas and Geitlerinema are introduced in general and, in particular, 
their abilities to produce bioactive substances including antibiotics are addressed. In 
addition, aspects of the ecological significance of both genera in their natural 
environments are reviewed.  
 
1.2.1 Genus Pseudoalteromonas 
 
The genus Pseudoalteromonas (Gr. adj. pseudês, false; N.L. fem. n. Alteromonas, 
the genus Alteromonas; N.L. fem. n. Pseudoalteromonas, false Alteromonas) was 
first described by Gauthier and coworkers (1995). Taxonomically this genus is to be 
placed within the family Pseudoalteromonadaceae, within the order 
Alteromonadales, in the class of the Gammaproteobacteria. Originally, many 
members of the mentioned genus were associated with the genus Alteromonas 
(Baumann et al., 1972; Novick and Tyler, 1985), but, based on phylogenetic 
analysis, the latter genus was taxonomically re-organised by Gauthier and coworkers 
(1995). The genus Pseudoalteromonas currently comprises 36 validly published 
species. A phylogenetic tree showing the taxonomic relationships of the 
Pseudoalteromonads is given in Figure 1.2 (page 14).  
Members of the genus Pseudoalteromonas can be found in various habitats of 
marine environments, often in association with marine eukaryotes such as algae, 
ascidians, mussels, sponges, and tunicates. Detailed overviews about the habitats of 
these organisms are given by Mikhailov and coworkers (2006) and by Bowman 
(2007). 
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Pseudoalteromonas strains are strictly aerobic, Gram-negative, non-sporeforming, 
slightly curved or straight, rod-shaped bacteria of 0.2-1.5 μm × 1.8-4.0 μm in size 
with a chemoheterotrophic metabolism (Mikhailov et al., 2006). Strains of most 
species are motile by a single unsheathed polar flagellum, but also unsheathed 
lateral flagella and/or sheathed polar flagella are reported for some species (Novick 
and Tyler, 1985; Enger et al., 1987; Holmström et al., 1998; Ivanova et al., 2000). 
All Pseudoalteromonads require Na+ ions for growth (Mikhailov et al., 2006), 
therefore, they could be regarded as obligately marine microorganisms. All species 
can grow at 20-25°C, most are able to grow at 4°C (Mikhailov et al., 2006). The 
substrate D-glucose is utilised by all of them (Mikhailov et al., 2006), except by 
P. distincta (Romanenko et al., 1995). 
 
The major part of the Pseudoalteromonas species is characterised by high hydrolytic 
activities and produces a variety of extracellular enzymes, such as alginases, 
amylases, caseinases, chitinases, DNAses, gelatinases, lecithinases, and lipases 
(Mikhailov et al., 2006). P. atlantica, P. carrageenovora, and some strains of P. citrea 
can decompose agar and/or carrageenan (Akagawa-Matsushita et al., 1992; Ivanova 
et al., 1998).  
 
Various Pseudoalteromonas species are secreting bioactive compounds of low and 
high molecular weight with algicidal, anti-fouling, antimicrobial as well as various 
pharmaceutically-relevant activities (Bowman, 2007) and, therefore, these organisms 
and their compounds are in the research focus of a large group of scientists from 
various countries, increasingly. The bioactive substances from Pseudoalteromonas 
species were so far classified as L-AAOs (Gómez et al., 2008; Mai-Prochnow et al., 
2008; Chen et al., 2010b; see also chapter 1.3, pages 22-24), cyclic peptides, 
polyanionic exopolymers, substituted phenolic and pyrolle-containing alkaloids, toxic 
proteins, and also several bromine-substituted agents (Bowman, 2007). 
P. phenolica, for example, is producing the low molecular weight brominated 
biphenyl compound MC21-A (3,3’,5,5’-tetrabromo-2,2’-diphenyldiol) with antibacterial 
activity against different MRSA strains (Isnansetyo and Kamei, 2003a,b; see also 
page 16, Figure 1.3 A). Egan and coworkers (2002) found that P. tunicata is 
producing at least four target-specific compounds with anti-fungal activities and at 
least two pigments, a yellow and a purple one. The yellow pigment itself also has 
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anti-fungal activity (Egan et al., 2002) and was identified as a tambjamine-like 
alkaloid, designated YP1 (Franks et al., 2005; see also Figure 1.3 B). Tambjamines 
are bioactive substances containing 4-methoxypyrrole, found in association with 
marine invertebrates, and are known to have antimicrobial, anti-proliferation, anti-
tumour, ichthyodeterrent, and immunosuppressive activities (Lindquist and Fenical, 
1991). They are likely acting as natural defensive substances against predators 
(Lindquist and Fenical, 1991). It seems that not the invertebrates themselves are the 
source of these substances, but bacteria, which are colonizing the surfaces of the 
higher organisms (König et al., 2006), like in the case of P. tunicata and its 
tambjamine-like alkaloid YP1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.3 A: Chemical structure of the brominated biphenyl compound MC21-A (Isnansetyo 
and Kamei, 2003b; figure used with the kind permission of the American Society for 
Microbiology). B: Chemical structure of the tambjamine-like alkaloid YP1 (Franks et al., 
2005; figure is free of copyright due to publication in the open access journal Molecules). 
 
As an example for the production of a high molecular weight compound, the 
Pseudoalteromonas species strain X153 was reported to secrete an unstable 
tetrameric protein of 280 kDa that also showed to have inhibitory activity against a 
broad spectrum of marine bacteria (Longeon et al., 2004). The same authors 
proposed strain X153 as an effective probiont, which is protecting commercial 
shellfish species against pathogenic Vibrio species.  
 
Pseudoalteromonas species are in various ways ecologically significant. They are 
known for influencing settlement (Holmström et al., 1996; Holmström et al., 2002; 
Dobretsov et al., 2007), germination (Egan et al., 2000, 2001) as well as 
metamorphosis (Leitz and Wagner, 1993; Negri et al., 2001) of various algae and 
 
A B 
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invertebrates (see also chapter 4, pages 130-132, Table 4.1). In addition, they seem 
to be involved in a predatory-like manner within the microbial loop (Lovejoy et al., 
1998; Skerratt et al. 2002). The latter mentioned author found swarming cells of 
Pseudoalteromonas strain ACEM 1 attracting to lysed cells of the dinoflagellate 
Gymnodinium catenatum providing the idea that the production of an unidentified 
algicidal substance is used with the function to supply nutrients for the bacterial 
species (see also page 18, Figure 1.4 A-D). According to the same author, the anti-
algal activity is at its maximum during the peak of the G. catenatum bloom, possibly 
triggered by a quorum sensing mechanism, and probably thus contribute to the 
disappearance of the bloom.  
Furthermore, members of the genus Pseudoalteromonas may also be hosted by 
marine fauna and flora for defence reasons (Lindquist and Fenical, 1991; Holmström 
et al., 1996; Holmström et al., 2002; Dobretsov et al., 2006; Dobretsov et al., 2007). 
As another important ecological feature, Pseudoalteromonads have been reported to 
influence biofilm formation in several marine habitats (Grossart et al., 2003; Mai-
Prochnow et al., 2004, 2006; Burmølle et al., 2006; Saravanan et al., 2006; Bayles, 
2007; Huang et al., 2007; Rao et al., 2010). In this respect, species such as 
P. aurantia (Gauthier and Breittmayer, 1979; Holmström et al., 2002) and P. citrea 
(Gauthier, 1977; Holmström et al., 2002; Patel et al., 2003; Kalinovskaya et al., 2004; 
Urvantseva et al., 2006) are of particular interest as the bioactive compounds formed 
by these species are preventing biofilm residents becoming overwhelmed by other 
colonising, potentially biofouling issue causing species (Grossart et al., 2003; Franks 
et al., 2006). In contrast to that, some members of the genus Pseudoalteromonas 
are highly effective in biofilm formation (Saravanan et al., 2006; Huang et al., 2007; 
Iijima et al., 2009) and accordingly may possibly cause biofouling. Thus, especially 
the algal polysaccharide degrading species P. agarivorans, P. atlantica, 
P. carrageenovora, and P. citrea (Akagawa-Matsushita et al., 1992; Romanenko 
et al., 2003a; Urvantseva et al., 2006) as well as the settlement of invertebrate larvae 
inducing species P. denitrificans, P. luteoviolacea, and P. spongiae (Hugget et al., 
2006; Huang et al., 2007) could be problematic in this regard. 
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Fig. 1.4 Images showing a time series of vegetative Gymnodinium catenatum cells after 
addition of algicidal culture supernatant from Pseudoalteromonas species strain ACEM 1. 
A: Typical cell chain of G. catenatum (T = 0-10 min). B: Cell chains disaggregate into single 
cells (T = 20 min). C: Cells get rounded (T = 45 min). D: Cell lysis and drain off (T = 3 h); the 
addition of strain ACEM 1 cells is also shown in this part of the figure to demonstrate 
swarming of these bacteria to a lysed cell of G. catenatum. T, time. Data and figures taken 
from Skerratt and coworkers (2002) and Bowman (2007); the figures are free of copyright 
due to publication in the open access journal Marine Drugs.  
 
Due to the fact that the hitherto studies included only a relatively small subset of 
Pseudoalteromonas strains in comparison to the known diversity of the genus, it can 
be reckoned that various more elucidating findings of novel bioactive compounds 
derived from members of this genus are very likely to be realised in the future. 
 
A B 
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1.2.2 Genus Geitlerinema 
 
The genus Geitlerinema (named in honour of Prof. Dr. Lothar Geitler) was first 
described by Anagnostidis (1989). Taxonomically this genus is to be placed within 
the family Pseudanabaenaceae (subfamily Pseudanabaenoideae), within the order 
Oscillatoriales, in the class of the Cyanophyceae. The genus Geitlerinema currently 
comprises 33 species, but none of them has been validly published under the 
Bacteriological Code of Nomenclature. Their descriptions are mainly based on 
morphological features, e.g. the cell nature and ultrastructure. According to the 
website of the Pasteur Culture Collection of Cyanobacteria (PCC), only two 
cyanobacteria have been validly published following the rules of the mentioned code, 
namely Prochlorothrix hollandica strain PCC 9006T (Burger-Wiersma et al., 1989) 
and Prochlorococcus marinus subsp. pastoris strain PCC 9511T (Rippka et al., 
2000).  
Phylogenetic trees, showing the taxonomic relationships of Geitlerinema species 
with good quality 16S rRNA gene sequences of >1200 bp in length available, can be 
found in chapter 3 (Manuscript III, pages 113-114, Figure 3) and in chapter 6 (pages 
158-159, Figure S4 and S5). 
 
Members of the genus Geitlerinema are ubiquitous and frequently occur in several 
kinds of environments, such as freshwater as well as marine habitats (Anagnostidis, 
1989; Romo et al., 1993; Margheri et al., 2003; Komárek and Anagnostidis, 2005). 
Overviews about the Geitlerinema habitats are given by Anagnostidis (1989) as well 
as Komárek and Anagnostidis (2005). 
 
As described by Anagnostidis (1989), Geitlerinema species are filamentous, 
unsheated, non-heterocystous, mostly bright blue-green cyanobacteria with 
cylindrical, straight trichomes of 1-4 μm width, which are motile by gliding (see also 
page 20, Figure 1.5 A-C). Detailed surveys of the morphological and of some 
physiological features of this genus are given by the same author and also by 
Komárek and Anagnostidis (2005). 
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Fig. 1.5 A: Main generic characteristics of Geitlerinema (obligatory features are underlined). 
Figure was taken from Anagnostidis (1989), with the kind permission of the Springer-Verlag. 
B: Photographs of Geitlerinema amphibium strain K-1090, deposited in the Scandinavian 
Culture Collection of Algae and Protozoa (SCCAP) at the University of Copenhagen. They 
were taken from the website of the SCCAP, with the kind permission of Dr. Gert Hansen 
(University of Copenhagen, Denmark). C: Scanning electron microscopy picture of 
Geitlerinema strain Flo1, kindly provided by Dipl. Biol. Jan Schrübbers (University of 
Bremen, Germany). The picture was taken by Dr. Herbert Juling (Amtliche 
Materialprüfungsanstalt, Bremen, Germany). 
 
Several Geitlerinema species are known for the production of bioactive compounds. 
Heyduck-Söller and Fischer (2000) found the culture supernatant of Geitlerinema 
strain Flo1 (in the mentioned study named Oscillatoria limnetica strain Flo1) to 
contain unidentified antibiotic compounds, which had growth inhibitory effects 
against several Gram-negative and Gram-positive bacteria as well as against the 
yeast Saccharomyces cerevisiae. Caicedo and coworkers (2010) reported that two 
different Amberlite-extracts of culture supernatant from strain Flo1 have antibacterial 
and antifungal activities, but the authors also did not identify the bioactive 
compound(s). Valdor and Aboal (2007) investigated Geitlerinema splendidum due to 
its bioactive potential. They revealed that the mentioned organism produces different 
A B 
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microcystins, whose secretion is postulated as the reason for growth inhibition and 
morphological as well as ultrastructural alterations of bacteria, cyanobacteria, and of 
a microalgae species (ultrastructural alterations were not observed for bacteria). 
Furthermore, Geitlerinema cf. sp. is producing a bioactive compound named 
mitsoamide, which is a linear peptide and has strongly cytotoxic activity against the 
human lung cancer cell line H-460 (IC50 460 nM) (Andrianasolo et al., 2007). 
 
Apart from the fact that Geitlerinema species as phototrophic organisms are 
producing O2, they have another important ecological role. Members of this genus 
are significant microbial mat-formers, especially their contribution concerning the 
black band disease (BBD) of corals seems to be relevant. The BBD is a pathogenic, 
sulfide-rich microbial mat, between 1 mm and several cm wide and up to 1 mm thick, 
which is dominated by different filamentous cyanobacteria species that infect corals 
on a global scale (Myers et al., 2007). The microbial mat migrates across the coral 
colonies in the shape of a band at rates averaging 3 mm per day and is able to kill 
whole colonies in a few months by separating apparently healthy tissue from freshly 
exposed coral skeleton (Rützler et al., 1983). In general, the BBD is comprised of a 
complex community of microbes consisting of various heterotrophic bacteria, of 
sulfide-oxidizing and sulfate-reducing bacteria as well as of non-heterocystous 
filamentous cyanobacteria (Gantar et al., 2009). Beyond the latter mentioned 
organisms, the presence of Geitlerinema species within this econiche was confirmed 
(Cooney et al., 2002; Myers et al., 2007; Richardson et al., 2007). Myers and 
coworkers (2007) found different BBD Geitlerinema and Leptolyngbya strains to 
prefer low light conditions and to carry out a sulfide-resistant oxygenic 
photosynthesis, which is relatively uncommon among cyanobacteria, thus most of 
them follow a strategy of sulfide-sensitive oxygenic photosynthesis, which involves 
an inhibition of photosynthesis even when low amounts of sulfide are present and, 
thereby, are considered to be obligate oxygenic phototrophs (Cohen et al., 1986). 
The advantage of carrying out a sulfide-resistant oxygenic photosynthesis is that it 
allows the BBD cyanobacteria to continue photosynthesizing despite that they are 
present below the oxygen/sulfide interface in the microbial mat (Myers et al., 2007). 
The ability of BBD cyanobacteria, including Geitlerinema species, to produce toxic 
compounds like microcystins (Richardson et al., 2007; Gantar et al., 2009; Stani	 et 
al., 2011), may be of an additional ecological importance. These toxins were 
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assumed to be one of the mechanisms assisting to BBD-associated coral tissue lysis 
and death (Gantar et al., 2009; Stani	 et al., 2011). 
 
Such as the Pseudoalteromonas species, also the members of the genus 
Geitlerinema, due to their production of biotechnologically and therapeutically 
relevant bioactive compounds, are promising research subjects and thereby valuable 
prospective discoveries are likely to be made. 
 
1.3 L-amino acid oxidases (L-AAOs) 
 
L-AAOs (L-amino acid: O2 oxidoreductase (deaminating), EC 1.4.3.2.) are 
flavoenzymes, typically with a dimeric structure, first described by Zeller and Maritz 
(1944). Flavin adenine dinucleotide (FAD) is the strongly but non-covalently bound 
cofactor of these enzymes (Pawelek et al., 2000). L-AAOs are catalysing the 
stereospecific oxidative deamination of L-amino acid substrates to the respective 
-keto acids (Du and Clemetson, 2002). The detailed chemical equation of the 
mentioned reaction is shown below: 
 
 
 
The release of hydrogen peroxide during this reaction is the reason for the 
antimicrobial activity of L-AAOs (Stiles et al., 1991) and for their contribution to the 
toxicity of snake venoms (Samel et al., 2008). Indeed, the best studied enzymes of 
this kind were derived from those venoms (Li et al., 1994; Souza et al., 1999; 
MacHeroux et al., 2001; Lu et al., 2002; Stábeli et al., 2007; Samel et al., 2008). 
L-AAOs can be separated in groups with a broader spectrum (Gómez et al., 2008) 
and in those which have a more strict substrate specificity (Lucas-Elío et al., 2006). 
Sources, substrate specificities, and the molecular weights of different L-AAOs are 
summarised in Table 1.1 (page 24).  
As can be seen in a part of Table 1.1, Gómez and coworkers (2008), Mai-Prochnow 
and coworkers (2008) as well as Chen and coworkers (2010b) recently found that 
the bioactive compounds of different P. luteoviolacea strains, P. tunicata strain D2 
respectively P. flavipulchra strain C2 are L-AAOs. Promisingly, the L-AAO from 
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P. flavipulchra was able to inhibit growth of several MRSA strains and other clinical 
relevant bacteria.  
Also different cyanobacteria are known for their production of L-AAOs or the 
presence of genes encoding for L-AAOs (Gau et al., 2007), but until now not 
including any species from the genus Geitlerinema. 
 
L-AAOs are found to have different functions. As mentioned above, they are 
contributing to the toxicity of snake venoms (Samel et al., 2008). Furthermore, 
Palenik and Morel (1990a,b) found several marine phytoplankton species to contain 
cell-surface located L-AAOs for the utilization of L-amino acids as a nitrogen source. 
The green microalga Chlamydomonas reinhardtii produces L-AAOs, which were also 
found to supply ammonia from L-amino acids, but only when no primary nitrogen 
source is available (Muñoz-Blanco et al., 1990; Piedras et al., 1992; Vallon et al., 
1993; see also page 24, Table 1.1). Bockholt and coworkers (1996) insertionally 
inactivated the aoxA gene encoding for the L-AAO of the cyanobacterium 
Synechococcus elongatus strain PCC 7942 with the effect that the organism could 
no longer grow with L-arginine as the sole N-source. The authors concluded that 
only the L-AAO enables strain PCC 7942 to utilize extracellularly added L-arginine 
as an N-source. In addition, Proteus rettgeri was found to have a membrane-bound 
L-AAO which probably interacts with the respiratory electron transport chain (Duerre 
and Chakrabarty, 1975). Apart from that, it has been reported that the red macroalga 
Chondrus crispus contains an L-AAO located in the apoplast which has a function in 
pathogen defence (Weinberger et al., 2005). Nagaoka and coworkers (2009) have 
shown that mice milk is containing an L-AAO which protects the mammary glands 
against bacterial infections due to the generation of hydrogen peroxide from L-amino 
acids present in the milk. Additionally, an L-AAO produced by Pseudoalteromonas 
tunicata was reported to play a crucial role during biofilm formation and dispersal 
(Mai-Prochnow et al., 2004, 2008; see also chapter 4.1, pages 122-123). 
Furthermore, Boulland and coworkers (2007) have shown that an L-AAO produced 
by human dendritic cells inhibits T-lymphocyte proliferation and, thus, has an 
immunomodulatory function.  
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Tab. 1.1 Sources, substrate specificities, and molecular weights (kDa) of different L-AAOs. 
 
Source 
 
Substrate specificity Molecular weight 
(kDa) 
Reference 
 
Bacteria 
 
   
Marinomonas mediterranea ATCC 700492  high (only L-Lys) ~140-170 Lucas-Elío et al., 2005, 
2006 
Pseudoalteromonas flavipulchra C2  low 60 Chen et al., 2010b 
Pseudoalteromonas luteoviolacea 
CPMOR-1 and CPMOR-2  
low 110 (only determined 
for strain CPMOR-2) 
Gómez et al., 2008 
Pseudoalteromonas tunicata D2  high (only L-Lys) 190 James et al., 1996; Mai-
Prochnow et al., 2008 
Rheinheimera sp. GR5  high (only L-Lys) 71 Chen et al., 2010a 
Streptococcus oligofermentans AS 1.3089 low 43 Tong et al., 2008 
 
Cyanobacteria 
 
 
 
 
 
 
 
Synechococcus elongatus PCC 6301 high (only basic amino 
acids) 
54 Gau et al., 2007 
 
Fungi 
 
 
 
 
 
 
 
Aspergillus nidulans MH1 low unknown Davis et al., 2005 
Trichoderma viride Y244-2 low 116 Kusakabe et al., 1980 
 
Algae 
 
 
 
 
 
 
 
Chlamydomonas reinhardtii CW15 (green 
microalga) 
very low (only L-Cys not) ~470, ~900-1000 and 
~1200-1300 
Piedras et al., 1992; 
Vallon et al., 1993 
Gymnogongrus flabelliformis (red 
macroalga) 
low unknown Fujisawa et al., 1982 
 
Gastropoda 
 
 
 
 
 
 
 
Aplysia californica (sea hare) high (only basic amino 
acids) 
60 Yang et al., 2005 
 
Insecta 
 
 
 
 
 
 
 
Venoms from several insect species only L-Leu was tested unknown Ahn et al., 2000 
 
Vertebrata 
 
 
 
 
 
 
 
Ink from Platichthys stellatus (flounder) unknown 52 Kasai et al., 2010 
Milk from Mus musculus (house mouse) 
Dendritic cells from Homo sapiens 
low 
high (only L-Phe and L-Trp) 
113 
62 
Sun et al., 2002 
Boulland et al., 2007 
Venom from Bothrops moojeni (fer-de-
lance) 
low 131 Stábeli et al., 2007 
Venom from Naja naja oxiana (central 
asian cobra) 
moderate 110 Samel et al., 2008 
 
 
In the last 10-15 years, L-AAOs came more and more into scientific focus due to 
their diverse effects on blood components (platelets), on cells (including cancer 
cells), and on various microorganisms (Samel et al, 2008). The production of 
D-amino acids by enzymatic resolution of racemic amino acid solutions is the main 
commercial application for L-AAOs (Parikh et al., 1958; Takahashi et al., 1997). 
Furthermore, these enzymes were frequently used in biochemical studies for the 
identification of optical isomers of amino acids, preparation of -keto acids, and 
production of thyroxine from 3,5-diiodotyrosine (Iwanaga and Suzuki, 1979). 
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1.4 Aims of the thesis 
 
The Pseudoalteromonas species P. aurantia NCIMB 2052T (Gauthier, 1977) and 
P. citrea NCIMB 1889T (Gauthier and Breittmayer, 1979) as well as the Geitlerinema 
strain Flo1 (Heyduck-Söller and Fischer, 2000; Caicedo et al., 2010) are known for 
their production of inhibitory substances, but the substantial nature and the 
mechanism of inhibition of these substances are still remaining unknown. 
 
Hence, regarding both Pseudoalteromonas species, the aims of the present study 
were 
 
i) to elucidate the antibacterial potential of the inhibitory substances derived 
from P. aurantia and P. citrea against several bacteria including MRSA 
and other clinical relevant strains, 
ii) to characterise these substances with respect to their functional nature by 
investigating the mechanism of inhibition as well as possible substrate 
spectra,  
iii) to develop a new method for in-gel detection of these substances during 
non-denaturing sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) to determine their approximate molecular weights and 
number, and 
iv) to investigate and compare different growth phases and parameters at 
which they are produced. 
 
Geitlerinema strain Flo1 was investigated 
 
i) to elucidate the functional nature of one of the inhibitory substances 
produced by this strain Flo1 by studying its mechanism of inhibition as well 
as its possible substrate spectrum, 
ii) to determine its approximate molecular weight by in-gel detection using 
the above mentioned newly developed method, and 
iii) to analyse the phylogenetic position of strain Flo1 amongst closely related 
cyanobacteria. 
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2. Material and Methods 
 
2.1 Culture media 
 
2.1.1 Lysogeny broth (LB) 
 
The LB was prepared according to Bertani (1951). The medium contained 
(l-1 distilled water) 10.0 g tryptone, 5.0 g yeast extract, and 10.0 g NaCl (pH 7.0). 
Solid LB contained (l-1 distilled water) 15.0 agar, additionally. 
 
2.1.2 Malt/yeast/glucose medium (MYG)  
 
The MYG medium contained (l-1 distilled water) 10.0 g malt extract, 4.0 g yeast 
extract, 20.0 g D-glucose, and 1.0 g (NH4)2HPO4 (pH 6.5). Solid MYG contained 
(l-1 distilled water) 15.0 agar, additionally. 
 
2.1.3 Tryptic soy broth (TSB) 
 
The TSB contained (l-1 distilled water) 17.0 g tryptone, 3.0 g soytone, 5.0 g NaCl, 
2.5 g D-glucose, and 2.5 g K2HPO4 (pH 7.3). Solid TSB contained (l-1 distilled water) 
15.0 agar, additionally. 
 
2.2 Microbial strains 
 
The heterotrophic bacteria Bacillus subtilis ATCC 6051T, Cupriavidus metallidurans 
DSM 2839T, Escherichia coli K12, Pseudoalteromonas aurantia NCIMB 2052T, 
Pseudoalteromonas citrea NCIMB 1889T, Pseudomonas fluorescens ATCC 13525T, 
and the yeast Saccharomyces pastorianus DSM 6580NT were obtained from the 
“Deutsche Sammlung von Mikroorganismen und Zellkulturen” (DSMZ; 
Braunschweig, Germany).  
The cyanobacterium Geitlerinema strain Flo1 was originally isolated by Dr. Jörg 
Rethmeier (University of Bremen, Germany) from a mangrove wood in Florida near 
Key Biscane and cultivated in the culture collection of the Department of Marine 
Microbiology at the University of Bremen (Germany). Geitlerinema PCC 7105 was 
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obtained from the Pasteur Culture Collection (Paris, France). Both strains were 
axenic, as evaluated by light microscopical studies. The cultivation of these strains 
was performed by Dipl. Biol. Jan Schrübbers (University of Bremen, Germany). 
The bacterial strain Escherichia coli UM255 (catalase negative mutant; Mulvey et al., 
1988) was kindly provided by Prof. Dr. Peter C. Loewen (University of Manitoba, 
Winnipeg, Canada). 
Clinical isolates of the S2 classified heterotrophic bacteria Enterococcus faecalis, 
MRSA, and Staphylococcus epidermidis were provided by courtesy of the Molzym 
GmbH (Bremen, Germany). All experiments regarding these S2 strains were 
performed in the laboratory of the mentioned company. 
 
2.3 16S rRNA gene sequence determination 
 
The identities of the Pseudoalteromonas and Geitlerinema strains were verified 
respectively evaluated by 16S rRNA gene sequence determination. Therefore, 
extraction of the genomic DNA and PCR were carried out as described by Neilan 
(1995). The two primers 8F (5´-AGAGTTTGATCCTGGC-3´) and 1494R 
(5´-GTACGGCTACTACGAC-3´) were used for amplification. PCR products were 
purified with the Qiagen QIAquickTM PCR product purification kit according to the 
manufacturer’s instructions, and DNA sequencing was performed by GATC Biotech 
(Konstanz, Germany), using 517F (5´-CCAGCAGCCGCGGTAA-3´) as an additional 
primer together with the two other ones mentioned. The sequences obtained from 
amplification were merged together with Chromas Pro version 1.34, resulting in 
nearly full-length 16S rRNA gene sequences. Finally, the identities of both 
sequences were determined by using the basic local alignment search tool (BLAST). 
In the case of both cyanobacterial strains, the whole procedure was performed by 
Dipl. Biol. Jan Schrübbers (University of Bremen, Germany). 
 
2.4 Phylogenetic analyses 
 
Phylogenetic analyses of 16S rRNA gene sequences were performed using the ARB 
software package (versions 5.1 and 5.2; Ludwig et al., 2004) and the corresponding 
SILVA SSURef 104 database (release October 2010; Pruesse et al., 2007). This 
dataset contains only good quality sequences of >1200 bp in length. The sequences 
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were aligned automatically using the PT server implemented in the ARB software 
package and the alignment was checked manually. Phylogenetic trees were 
reconstructed according to the neighbour-joining (Saitou and Nei, 1987), maximum-
parsimony (Fitch, 1971), and maximum-likelihood (Felsenstein, 1981) methods. The 
stability of the groupings was estimated by bootstrap analysis (Felsenstein, 1985) of 
the neighbour-joining and maximum-parsimony methods based on 1,000 
replications. 
 
2.5 Cross-flow filtration 
 
The sterile filtrated (0.2 
m cellulose acetate filter; Schleicher & Schuell) bacterial 
culture supernatants of P. aurantia, P. citrea, and of Geitlerinema strain Flo1 were 
concentrated via cross-flow filtration, which was realised by using a pump-system 
(pump: Masterflex L/S Economy Drive; pump head: Masterflex L/S Easy Load 
7518-00) in combination with a cross-flow filtration module (Vivaflow 50; molecular 
weight cut off, MWCO: 10 kDa; polyethersulfone; Sartorius). The concentrated 
solutions were stored at -20°C until usage.  
 
2.6 PAGE 
 
PAGE was performed at 150 V using a vertical gel electrophoresis chamber 
(omniPAGE mini-System E-VS10-SYS; Biocom). Protocols for the preparation of the 
polyacrylamide gels with 40% acrylamide and 2% bis-acrylamide solutions according 
to Laemmli (1970) are given in Table 2.1 (page 29). For native PAGE the same 
protocols were used with the modification that all solutions were prepared without 
SDS.  
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Tab. 2.1 Composition of the stacking and resolving gels according to Laemmli (1970). 
Acrylamide concentration  
 
Stacking gel 
 
Resolving gel 
Solution 
4% 6% 10% 
40% Acrylamid 240 μl 730 μl 1.213 ml 
2% Bis-acrylamid 130 μl 402 μl 667 μl 
4x 0.5 M Tris-HCl, pH 6.8, 0.4% SDS 630 μl - - 
4x 1,5 M Tris-HCl, pH 8.8, 0.4% SDS - 1.25 ml 1.25 ml 
Distilled water 1.485 ml 2.563 ml 1.8425 ml 
N,N,N',N'-Tetramethylethylenediamine (TEMED) 5 μl 5 μl 5 μl 
10% Ammonium persulfate 25 μl 50 μl 50 μl 
Total volume 2.5 ml 5 ml 5 ml 
 
 
More detailed information regarding the used materials and methods are given in the 
respective manuscripts (see chapter 3: Manuscript I, pages 37-42; Manuscript II, 
pages 66-70; Manuscript III, pages 93-98; Manuscript IV, pages 117-118). 
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3. Manuscripts 
 
Explanation to my own contribution to each manuscript.  
 
Manuscript I: Properties of bioactive substances produced by 
Pseudoalteromonas aurantia and Pseudoalteromonas citrea inhibiting growth 
of methicillin-resistant Staphylococcus aureus 
 
Rau JE, Havemeyer S, and Fischer U (2011) Properties of bioactive substances 
produced by Pseudoalteromonas aurantia and Pseudoalteromonas citrea inhibiting 
growth of methicillin-resistant Staphylococcus aureus. Intended for publication in 
“Enzyme and Microbial Technology”. 
 
This manuscript is describing the initial characterisation of the inhibitory substances 
produced by two different Pseudoalteromonas strains. 
The experimental setup was designed by me and I carried out all the laboratory 
work, except the experiments concerning the pH and temperature stability of the 
inhibitory substances which were performed by Sandra Havemeyer. Data analyses 
and writing were done by me, with support and input from all co-authors.   
 
Manuscript II: Inhibitory substances from Pseudoalteromonas aurantia and 
Pseudoalteromonas citrea are L-amino acid oxidases with broad substrate 
spectra 
 
Rau JE, Grundmann O, and Fischer U (2011) Inhibitory substances from 
Pseudoalteromonas aurantia and Pseudoalteromonas citrea are L-amino acid 
oxidases with broad substrate spectra. Intended for publication in “Enzyme and 
Microbial Technology”. 
 
Results concerning the further characterisation of the inhibitory substances produced 
by two different Pseudoalteromonas strains are revealed in this manuscript. 
I developed the experimental setup and performed out all the laboratory work. Data 
analyses and writing were done by me, with support and input from all co-authors. 
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Manuscript III: L-lysine oxidase: an inhibitory substance produced by the 
marine filamentous cyanobacterium Geitlerinema strain Flo1 
 
Schrübbers JP, Rau JE, and Fischer U (2011) L-lysine oxidase: an inhibitory 
substance produced by the marine filamentous cyanobacterium Geitlerinema strain 
Flo1. Submitted to “Zeitschrift für Naturforschung C” on June 7, 2011. 
 
This manuscript is describing the characterisation of an inhibitory substance 
produced by Geitlerinema strain Flo1 and its phylogenetic positioning within the 
genus Geitlerinema and closely related cyanobacteria. 
For the following parts of the manuscript I have designed the experimental setup, 
carried out the laboratory work, and analysed the data: SDS-PAGE, in-gel 
antibacterial assays, and investigation of the substrate spectrum of the inhibitory 
substance using a spectrophotometric assay. In addition, I re-constructed the 
phylogenetic trees. The manuscript was written by Jan Schrübbers and me, with 
support and input from the third author. 
 
Manuscript IV: In-gel detection of L-amino acid oxidases based on the 
visualisation of hydrogen peroxide production 
 
Rau JE, Fischer U (2011) In-gel detection of L-amino acid oxidases based on the 
visualisation of hydrogen peroxide production. J Microbiol Methods 85:228-229 
 
This manuscript is dealing with the description of an easy and practicable technique 
for in-gel detection of L-amino acid oxidases after non-heating SDS-PAGE based on 
the visualisation of occurring hydrogen peroxide production. 
I had the idea for the experimental setup and carried out the practical work. Data 
analyses and writing were performed by me, with support and input from the second 
author. 
 
All manuscripts are formatted according to the rules of the respective journals. 
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Other publications (not part of the thesis) 
 
Rau JE, Blotevogel KH, and Fischer U (2011) Algoriphagus aquaeductus sp. nov., 
isolated from a freshwater pipe. International Journal of Systematic and Evolutionary 
Microbiology, in press, doi: 10.1099/ijs.0.030809-0. 
 
Bock M and Rau JE (2011) Growth and carotenoid synthesis of different 
Algoriphagus species in dependence of oxygen saturation and phosphate 
concentration. Submitted to “Zeitschrift für Naturforschung C” on April 1, 2011. 
 
Poster communications 
 
Rau JE, Blotevogel KH, and Fischer U (2007) Hongiella aquaeductus - a new 
aggregate-forming bacterium - isolated from a freshwater pipe. Biospektrum 
Sonderausgabe, Tagungsband zur VAAM-Jahrestagung 2007, p. 151. 
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Abstract 26 
 27 
In the present study, the inhibitory substances produced by Pseudoalteromonas 28 
aurantia NCIMB 2052T and Pseudoalteromonas citrea NCIMB 1889T have been 29 
investigated. The results reveal that these substances are able to strongly inhibit the 30 
growth of methicillin-resistant Staphylococcus aureus (MRSA; clinical isolate, 31 
Molzym GmbH, Bremen) and Staphylococcus epidermidis (clinical isolate, Molzym 32 
GmbH, Bremen) as well as several other microbial strains. The inhibitors are 33 
produced in the late exponential to stationary growth phase. Catalase, peroxidase, 34 
and proteinase K are neutralising the antibacterial activity of the inhibitory 35 
substances, whereas -amylase and trypsin not. Hence, their substantial nature is 36 
very likely to be proteinogenous and hydrogen peroxide might be involved in the 37 
mechanism of antibacterial action. Isoelectric points of the inhibitory substances are 38 
8.7 (P. aurantia) respectively 8.9 and 9.4 (P. citrea). Thus, most probably P. aurantia 39 
is producing only one inhibitory substance, whereas P. citrea is producing two. 40 
Thermolability and resistance of the inhibitory substances to acid-alkaline treatment 41 
is proven. This is one of the first reports on marine bacteria from the genus 42 
Pseudoalteromonas with high antibacterial potential against MRSA. 43 
 44 
Keywords: Agar diffusion test, antibacterial activity, antibiogram, methicillin-resistant 45 
Staphylococcus aureus (MRSA), Pseudoalteromonas aurantia, Pseudoalteromonas 46 
citrea  47 
                                                                                                                   Manuscript I 
Abbreviations: 
Artificial sea water (ASW); methicillin-resistant Staphylococcus aureus (MRSA)  
36
1. Introduction 48 
 49 
Antibiotics are defined as any substances produced by microorganisms, which are 50 
antagonistic upon growth of other microorganisms in high dilution [1]. Antibiotics may 51 
be intermediates, end or waste products of the metabolism as well as other 52 
compounds, which have antibiotic properties [2]. The use of antibiotics was 53 
groundbreaking in the fight against several diseases, such as endocarditis, 54 
gonorrhea, meningitis, pneumonia, septicaemia, and tuberculosis [3-5]. However, 55 
pathogenic microbial organisms that have become resistant to antibiotic therapy are 56 
an increasing problem for the public health [6]. The fact that microbes are highly 57 
stressable and have processed various ways to resist antibiotics is one part of the 58 
problem [7,8]. The increasing use and misuse of existing antibiotics in human and 59 
veterinary medicine and in agriculture is another one [9]. A species, which is highly 60 
problematic in the current time, is the methicillin-resistant Staphylococcus aureus 61 
(MRSA) [10,11]. As bacteria are continuously overcoming the medical tools for the 62 
fight against them, there is a constant need concerning the search for new antibiotics 63 
that affect the target [12-14]. 64 
An overview about the history, physiological features, and ecological significance of 65 
the genus Pseudoalteromonas was recently given by Bowman [15]. The author 66 
reviewed that the genus Pseudoalteromonas contains numerous marine species 67 
synthesizing biologically active substances which act upon a variety of target 68 
organisms. According to Bowman [15], this seems to be a unique characteristic for 69 
this genus and may greatly benefit Pseudoalteromonas cells in their competition for 70 
nutrients and colonisation of habitats. Furthermore, the author pointed out that many 71 
members of this genus are producing bioactive substances of low and high72 
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molecular weight with antimicrobial, anti-fouling, algicidal and various 73 
pharmaceutically-relevant activities.  74 
Pseudoalteromonas aurantia NCIMB 2052T and Pseudoalteromonas citrea 75 
NCIMB 1889T are marine bacteria, which are also known to produce polyanionic 76 
antibiotics [16,17]. Their substantial nature as well as the mechanism of inhibition are 77 
still remaining unknown. 78 
The objectives of this paper are i) to elucidate the antibacterial potential of the 79 
inhibitory substances derived from P. aurantia and P. citrea upon several bacteria 80 
including MRSA and other clinical relevant strains, ii) to partially characterise these 81 
substances and their mechanism of action as well as iii) to investigate and compare 82 
different growth phases and parameters at which they are produced.    83 
 84 
2. Materials and Methods 85 
 86 
2.1 Bacterial strains and culture conditions 87 
 88 
Pseudoalteromonas aurantia NCIMB 2052T and Pseudoalteromonas citrea 89 
NCIMB 1889T were cultivated using artificial sea water (ASW), modified after Kester 90 
et al. [18]. The medium contained (l-1 distilled water) 5.0 g Casamino acids, 1.0 g 91 
yeast extract, 1.0 g glucose, 17.54 g NaCl, 18.49 g MgSO4·7H2O, 1.12 g KCl, 2.21 g 92 
CaCl2·2H2O, 150.0 mg KBr, 50.0 mg Fe(III) citrate, 10.0 mg KH2PO4 (pH 7.5). Solid 93 
ASW contained (l-1 distilled water) 15.0 agar, additionally. The culture medium was 94 
adjusted to pH 7.6. In dependence of the assay to be performed and if not otherwise 95 
stated, cultivation was routinely performed at 26°C (P. aurantia) respectively 21°C 96 
(P. citrea) for 1-4 d on either solid or in liquid ASW by shaking at 150 rpm. In the 97 
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latter case, an OD600 of 0.1 was used to inoculate the bacterial cultures. Cultivation 98 
of the target organisms was routinely performed at the optimal growth temperature of 99 
the particular strains as described for the Pseudoalteromonads (further details see 100 
Table 1). Microorganisms were maintained at -80°C in appropriate medium with 30% 101 
(v/v) glycerol. 102 
 103 
2.2 Preparation of concentrated supernatants 104 
 105 
P. aurantia and P. citrea were grown in 1 l ASW for 24 h in 2 l Erlenmeyer flasks as 106 
described. The bacterial culture supernatants were collected by centrifugation at 107 
10,000 rpm and 4°C for 60 min and sterile filtered. 50-fold concentration of the sterile 108 
supernatants was performed using pressure filtration with a cut off value of 10 kDa. 109 
Storage was done by freezing at -20°C.        110 
 111 
2.3 Antibiograms 112 
 113 
The antibacterial potential of concentrated bacterial culture supernatants from 114 
P. aurantia and P. citrea was investigated using agar diffusion tests, based on the 115 
method described by Bauer et al. [19] with the following modifications. Circular wells 116 
with a diameter of 6 mm were cut into the surface of an agar plate (type of medium 117 
depending on target organism; see Table 1). Approximately 15 ml agar medium were 118 
used per plate. Cultures of test strains (60 μl; OD600 = 0.1) were plated onto the agar 119 
surface using a Drigalski spatula. 50 μl of concentrated bacterial culture supernatant 120 
respectively of the control were added into the wells and zones of inhibition were 121 
determined after 24 h of incubation at the optimal growth temperature of the 122 
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particular target organism. As a control, 0.03% H2O2 solution was used. Mean 123 
diameters of inhibition zones were quantified by subtracting the diameter of the well 124 
(6 mm). Tests were performed in quadruplicate.  125 
Antibacterial activities of the inhibitory substances produced by P. aurantia and 126 
P. citrea were checked with the following organisms: Bacillus subtilis ATCC 6051T, 127 
Cupriavidus metallidurans DSM 2839T, Enterococcus faecalis (clinical isolate, 128 
Molzym GmbH, Bremen), Escherichia coli K12, catalase negative mutant 129 
Escherichia coli UM255 [20], Pseudoalteromonas aurantia NCIMB 2052T, 130 
Pseudoalteromonas citrea NCIMB 1889T, Pseudomonas fluorescens ATCC 13525T, 131 
methicillin-resistant Staphylococcus aureus (MRSA; clinical isolate, Molzym GmbH, 132 
Bremen), Staphylococcus epidermidis (clinical isolate, Molzym GmbH, Bremen), and 133 
the yeast Saccharomyces pastorianus DSM 6580NT. 134 
 135 
2.4 Growth and secretion of inhibitory substances under standard conditions 136 
 137 
Production of the inhibitory substances during growth of P. aurantia and P. citrea 138 
was determined under standard incubation conditions. The organisms were grown in 139 
10 ml of ASW in 100 ml-Erlenmeyer flasks as described. Growth was followed by 140 
measuring the turbidity of the cultures spectrophotometrically at 600 nm against 141 
ASW. In addition, 150 μl per test culture were sampled, centrifuged at 13,000 rpm 142 
and 4°C for 15 min, and frozen at -20°C until usage for the detection of antibacterial 143 
activity by agar diffusion tests. OD measurements and sampling were done every 2 h 144 
over a period of 36 h. The agar diffusion tests were performed as mentioned using 145 
the catalase negative mutant Escherichia coli UM255 as target organism, except that 146 
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the strain was not plated onto the solid agar but the LB agar medium was inoculated 147 
with an OD600 of 0.001 before pouring (plates were stored at most for 7 d). 148 
 149 
2.5 Growth and secretion of inhibitory substances at low and high incubation 150 
temperatures 151 
 152 
Production of inhibitory substances during growth of P. aurantia and P. citrea was 153 
determined under low in comparison to high temperature conditions. The incubation 154 
parameters were 26°C (P. aurantia) respectively 21°C (P. citrea) and 10°C (for both); 155 
without shaking. The organisms were grown in 10 ml of ASW in 100 ml-Erlenmeyer 156 
flasks. Inoculation of test cultures, measurement of growth, sampling, and agar 157 
diffusion tests were performed as described, except that OD measurements and 158 
sampling were done every 24 h over a period of 16 d. 159 
 160 
2.6 Effect of selected enzymes upon antibacterial activity  161 
 162 
The effect of selected enzymes upon activities of inhibitory substances produced by 163 
P. aurantia and P. citrea was investigated using agar diffusion tests, with the 164 
following modifications. Additional circular wells from the same size were cut 165 
neighbouring to the already existing ones (approximately 5 mm space between the 166 
corresponding wells), in which the concentrated bacterial culture supernatants were 167 
filled. Aqueous enzyme solutions were added into the additional wells (final volume 168 
50 μl). The following enzymes were tested: 0.25 mg -amylase from human saliva 169 
(AppliChem, 100 units/mg), 5 μl catalase from Aspergillus niger (AppliChem, 170 
5300 units/ml), 0.2 mg peroxidase from horseradish (Sigma, 116 units/mg), 0.8 mg 171 
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proteinase K from Tritirachium album (AppliChem, 30 units/mg), and 0.025 mg 172 
trypsin from porcine pancreas (Sigma, 1120 units/mg). Proteinase K and trypsin 173 
were activated with 5 mM CaCl2. Enzyme solutions as well as distilled water without 174 
concentrated bacterial culture supernatant next to them were used as additional 175 
controls. Appearing inhibition of antibacterial activity was documented by the eclipse 176 
of the inhibition zones. Tests were performed in quadruplicate.  177 
 178 
2.7 Isoelectric precipitation 179 
 180 
Isoelectric precipitation was carried out to elucidate possible isoeletric points of the 181 
inhibitory substances produced by P. aurantia and P. citrea. Both organisms were 182 
cultivated and supernatants were collected as described, except that the 183 
supernatants were not concentrated and not frozen before usage. The isoelectric 184 
precipitation was performed according to Chen et al. [21]. Agar diffusion tests were 185 
performed as described using the catalase negative mutant Escherichia coli UM255 186 
as target organism.  187 
 188 
2.8 Temperature and pH stability of inhibitory substances 189 
 190 
Temperature and pH stability of the inhibitory substances produced by both 191 
Pseudoalteromonas strains were investigated as described by Chen et al. [22], with 192 
the following modifications. The sources of inhibitory substances were bacterial 193 
culture supernatants. Cultivation and harvesting were performed as mentioned. The 194 
supernatants were incubated at 20, 50, 60, 70, and 80°C in a water bath over a 195 
period of 30 min. After this treatment, the samples were cooled in crushed ice and 196 
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stored until usage at 4°C. Determination of pH stability was evaluated in the range of 197 
pH 5-10 in intervals of one pH unit by adjusting the culture supernatants to the 198 
appropriate values. Conditions were maintained over 3 h before each sample was 199 
readjusted to its initial pH value of 7.6. Agar diffusion tests were carried out as 200 
described with S. epidermidis as target organism. Samples without treatment served 201 
as controls. Tests were performed in quadruplicate. 202 
 203 
If not otherwise stated, all tests were performed in duplicates. 204 
 205 
3. Results and Discussion 206 
 207 
3.1 Antibacterial potential of inhibitory substances 208 
 209 
The antibacterial effect of the inhibitory substances produced by P. aurantia and 210 
P. citrea was checked against 11 microbial strains, thereof 3 clinical isolates and 211 
8 laboratory strains (Table 1). The overall inhibition patterns were nearly in total not 212 
significantly different for both inhibitor producing strains. Hence, it could be 213 
concluded that the substantial nature and also the concentration of the inhibitory 214 
substances in the samples of both Pseudoalteromonads might be quite similar. From 215 
all tested nosocomial strains, MRSA as well as S. epidermidis were highly 216 
susceptible to the inhibitory substances of both Pseudoalteromonas strains. This 217 
reveals that those inhibitors might possibly be used in future as new therapeutic 218 
antibiotic agents against both Staphylococci. Chen et al. [22] recently described that 219 
P. flavipulchra C2 also produces an inhibitory substance being an antibacterial 220 
protein, which inhibits growth of several clinical isolates, including 15 MRSA strains.   221 
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The nosocomial strain E. faecalis tested in the present study showed only weak 222 
susceptibility. The highest inhibitions of 20 mm each were found when the catalase 223 
negative mutant Escherichia coli UM255 was used as target organism. This 224 
suggests that catalase probably plays an important role in the neutralisation of the 225 
inhibitory effects. When P. aurantia NCIMB 2052T was first described by Gauthier 226 
and Breittmayer [17], they found a total lack of the antibacterial activity when the 227 
organism was grown on blood-containing media. This phenomenon was explained 228 
by the catalase activity of blood and was previously described for P. citrea 229 
NCIMB 1889T and P. rubra NCIMB 1890T [16,23]. In the present study both 230 
Pseudoalteromonas strains NCIMB 2052T and NCIMB 1889T were not only used as 231 
source of inhibitory substances but additionally also as target organisms, revealing 232 
that both Pseudoalteromonas strains exhibited autoinhibition. Holmström et al. [24] 233 
investigated the antibacterial activity expressed by 10 different Pseudoalteromonas 234 
species, including P. citrea NCIMB 1889T. The authors also found that P. citrea does 235 
inhibit its own growth, but that P. rubra NCIMB 1890T and P. tunicata exhibited only 236 
weak autoinhibitions. The other Pseudoalteromonads tested by Holmström et al. [24] 237 
did not show autoinhibition. The results of the present study revealed that E. coli K12 238 
was nearly resistant to the antibacterial effect of the inhibitory substances, whereas 239 
B. subtilis was not affected at all. Most probably, both strains are producing catalase 240 
in a concentration which is able to nearly respectively completely neutralise the 241 
antibacterial effects of the inhibitors. The yeast S. pastorianus exhibited moderate 242 
and only partial inhibition when being in contact with the inhibitory substances 243 
produced by P. aurantia, whereas those from P. citrea had no effect on the growth.  244 
 245 
3.2 Secretion patterns for inhibitory substances  246 
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 247 
To elucidate in which growth phase the inhibitory substances were secreted into the 248 
medium, P. aurantia and P. citrea were grown under standard incubation conditions 249 
and growth as well as the presence of inhibitors were checked every 2 h (Fig. 1 A 250 
and B).  251 
As can be seen, antibacterial activity could be detected in the culture medium of 252 
P. aurantia after 6 h in the late exponential growth phase for the first time. The strain 253 
showed no real stationary phase by turning directly into the declining phase. Most 254 
probably this is due to the presence of the inhibitory substance and the fact that 255 
P. aurantia is showing the phenomenon of autoinhibition. The highest inhibitor 256 
production could be detected after 12 h over a period of 6 h. Thereafter, the 257 
antibacterial activity became weaker until till the end of the experiment but did not 258 
disappear completely. It seems that there is a direct correlation between the course 259 
of the declining phase and inhibitor production, for which the autoinhibition of 260 
P. aurantia might be the driving force. 261 
Similar behaviour was observed for P. citrea with the exception that the inhibitory 262 
activity first could be detected at the beginning of the declining growth phase after 263 
12 h and that the highest inhibitor production lasted only for 2 h.     264 
These results clearly have shown that P. aurantia is already secreting its inhibitory 265 
substance in the late exponential growth phase, whereas P. citrea starts secreting at 266 
the beginning of the declining phase. This is in accordance with findings of Chen 267 
et al. [22] obtained with P. flavipulchra strain C2 where the antibacterial protein 268 
production started when strain C2 entered the stationary growth phase. McCarthy 269 
et al. [25] reported similar results for P. luteoviolacea strain 9K-V10. This strain starts 270 
to produce an antibacterial protein during late exponential to stationary growth 271 
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phase. The point in time when the synthesis of inhibitory substances starts is 272 
possibly triggered by quorum sensing mechanisms [15].  273 
 274 
The production of inhibitory substances during growth of P. aurantia and P. citrea at 275 
low (10°C without shaking) and high incubation temperatures (26 respectively 21°C 276 
without shaking) is documented in Fig. 2 A and B.  277 
As can be seen, growth of both Pseudoalteromonas strains started immediately and 278 
reached their maxima at their optimal incubation temperature already after 1 d before 279 
directly entering their declining growth phases which remained more or less constant 280 
after 6 d of incubation. Growth at 10°C exhibited short lag-phases, and maximum 281 
growth occurred after 4 and 9 d respectively. Regarding production of the inhibitory 282 
substances, differences have been observed for both strains. P. aurantia produced 283 
the inhibitor only at 26°C during the whole time of incubation but not at 10°C 284 
(Fig. 2 A). This is in contrast to findings with P. citrea. This organism produced the 285 
inhibitory substance at 21°C with decreasing activity only during the first 3 d of 286 
incubation, while at 10°C the production of inhibitor started in the middle of the 287 
exponential growth phase reaching maximum activity at its end and the beginning of 288 
the declining one (Fig. 2 B).  289 
Gauthier and Breitmayer [17] reported that the production of antibiotic compounds by 290 
P. aurantia strain NCIMB 2052T was constant and independent of incubation 291 
temperature. This is in contrast with our observations with the same strain, since no 292 
inhibitor production was found at 10°C and the production was lesser at 21 than at 293 
26°C (data not shown). This different production behaviour might be due to the use 294 
of diverse growth media, artificial seawater in the present study, and marine broth 295 
(Difco) in that of Gauthier and Breitmayer [17]. Regarding the production of inhibitory 296 
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substances by P. citrea strain NCIMB 1889T, Gauthier [16] reported that higher 297 
levels were formed at low temperatures. This finding is only partially in accordance 298 
with the results obtained in the present study with the same strain, since the activity 299 
of inhibitors produced at 10 or 21°C did not differ significantly. On the other hand, 300 
more inhibitory substances were formed when the strain was grown by shaking with 301 
150 rpm at 21 rather than at 26°C (data not shown). 302 
 303 
3.3 Characterisation of inhibitory substances 304 
 305 
The effect of selected enzymes on the activity of inhibitory substances produced by 306 
P. aurantia and P. citrea was examined using agar diffusion tests (Table 2). 307 
As can be seen, the antibacterial activities of the inhibitory substances produced by 308 
P. aurantia respectively P. citrea were neutralised in the presence of catalase, 309 
peroxidase, and proteinase K but not by -amylase or trypsin. Due to the facts that 310 
the antibacterial activities are neutralised by catalase and peroxidase, it is obvious 311 
that possibly hydrogen peroxide is involved in the mechanism of inhibition. The 312 
neutralisation caused by proteinase K indicates that the produced inhibitory 313 
substances might probably be rather of proteinogenous than of amylaceous nature, 314 
since treatment with -amylase had no neutralising effect. The fact that the 315 
antibacterial activity is not neutralised by trypsin might be an indication that the 316 
inhibitory substances have only a low content of arginine- and lysine-residues, or 317 
that these amino acids are located in the central parts of the inhibitory proteins 318 
without any access for an enzymatic attack by trypsin. Controls with enzyme 319 
solutions alone or destilled water had no effects on the growth of the used target 320 
organism.     321 
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The neutralising effect of catalase respectively the involvement of hydrogen peroxide 322 
in the mechanism of inhibition was previously described not only for P. aurantia and 323 
P. citrea but also for other Pseudoalteromonads [15-17,22,26). Chen et al. [22] as 324 
well as Gómez et al. [26] reported that the inhibitory substances of P. flavipulchra 325 
strain C2 respectively different P. luteoviolacea strains are L-amino acid oxidases 326 
(L-AAOs). L-AAOs (L-amino acid: O2 oxidoreductase (deaminating), EC 1.4.3.2.) are 327 
flavoenzymes catalysing the oxidative deamination of L-amino acids to the 328 
respective -keto acids with the release of ammonium and hydrogen peroxide [27] 329 
which determines the antimicrobial property of L-AAOs [28]. According to the 330 
findings from the present study that hydrogen peroxide is involved in the inhibition 331 
mechanism of the inhibitory substances of P. aurantia and P. citrea, it is likely that 332 
these substances are also L-AAOs. It is known that diverse media contain distinct 333 
types and amounts of amino acids which will have an influence on the activity of 334 
L-AAOs [21,22,26]. Gauthier [16] had recognised already such an effect concerning 335 
the intensity of the inhibitory activity due to the kind of nutrients supplied to P. citrea. 336 
This is confirmed also by our study (data not shown). Therefore, these findings 337 
additionally confirm the assumption that the inhibitory substances of P. aurantia and 338 
P. citrea are possibly L-AAOs. 339 
 340 
Culture supernatants of both Pseudoalteromonas strains were subjected to 341 
isoelectric precipitation in order to determine the isoelectric points of the inhibitory 342 
substances. As can be seen from Fig. 3, P. aurantia produced only one substance 343 
with an isoelectric point at 8.7 with inhibitory potential (Fig. 3 A), while P. citrea 344 
produced two with isoelectric points at pH 8.9 and pH 9.4 (Fig. 3 B). All other 345 
fractions showed no activity. Gauthier [16] also found two different polyanionic 346 
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inhibitory substances produced by P. citrea strain NCIMB 1889T by using an 347 
electrophoresis setup with Cellogel strips. Chen et al. [22] determined an isoelectric 348 
point of pH 9.4 for a protein of the supernatant of P. flavipulchra strain C2 with 349 
antibacterial activity. This implies that the inhibitory substances found at pH 9.4 from 350 
P. citrea (during the present study) and P. flavipulchra might have similar properties 351 
concerning structure and electrical charge.   352 
 353 
As can be seen from Fig. 4 A, thermostability of the inhibitory substance of 354 
P. aurantia is much better than that of P. citrea when the samples were pre-355 
incubated at the appropriate temperatures for 30 min. The antibacterial activity of the 356 
substance produced by P. aurantia remained constant until 50°C. Above this 357 
temperature, the activity slowly decreased to about 66% at 70°C. No activity was 358 
found at 80°C. This is in contrast to the observation with P. citrea where the activity 359 
decreased enormously to only 25% at 50°C, and no one could be detected above 360 
this temperature. The inhibitory substances of both Pseudoalteromonas strains 361 
tested in the present study kept their full antibacterial activity even after having been 362 
stored at - 20°C for 1.5 years (data not shown). 363 
 364 
Chen et al. [22] postulated that the antibacterial protein produced by P. flavipulchra 365 
strain C2 still had its full inhibitory activity after incubation at 50°C but was lost totally 366 
at 70°C, in each case after 30 min incubation. These findings are only partially in 367 
accordance with the results obtained in the present study with P. aurantia, since its 368 
inhibitory substance was still active at 70°C (Fig. 4 A). Thermolability was also 369 
reported for the inhibitory substances produced by other species of the genus 370 
Pseudoalteromonas [15]. The fact that the inhibitory substances produced by 371 
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P. aurantia and P. citrea are as thermolabile as those of different 372 
Pseudoalteromonads which are proteins, can be taken as a further indication that the 373 
inhibitory substances of both these organisms are also of proteinogenous nature.     374 
 375 
Concerning the pH stability of the inhibitory substances produced by both 376 
Pseudoalteromonas strains used, it could be shown that the intensity of the 377 
antibacterial activity was not undergoing significant changes in the tested pH range 378 
from 5-10, with the only difference that the antibacterial activity of P. citrea was 379 
totally lost at pH 5 (Fig. 4 B). 380 
This is mainly in accordance with results obtained for P. flavipulchra strain C2 whose 381 
activity of its antibacterial protein remained unaltered after being kept at pH-values 382 
ranging from 2-12 for 2 h [22]. Gauthier and Breittmayer [17] also found similar 383 
results for P. aurantia when the organism was grown in the pH range from 5-11. 384 
 385 
4. Conclusions 386 
 387 
In the present study it could be shown that the production of the inhibitory 388 
substances by P. aurantia and P. citrea occurs during the late exponential to 389 
stationary growth phase, respectively. When incubated at 10°C, P. citrea is 390 
producing inhibitory substances, whereas P. aurantia does not. It could be revealed 391 
that the inhibitory substances of both Pseudoalteromonads are thermolabile and 392 
nearly resistant to acid-alkaline treatment. Various clear hints could be found that the 393 
inhibitors are of proteinogenous nature and that the involvement of hydrogen 394 
peroxide in the mechanism of antibacterial activity is likely. Referring to the results 395 
obtained by isoelectric precipitation, P. aurantia is probably producing one inhibitory 396 
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substance, whereas P. citrea might produce two. Taking into account the results 397 
obtained for other species of the genus Pseudoalteromonas [22,26], the inhibitory 398 
substances produced by P. aurantia and P. citrea might be L-AAOs also. It might be 399 
possible that the inhibitors will find an application as new therapeutic antibiotic 400 
agents against MRSA und S. epidermidis. However, further comprehensive studies 401 
are necessary to clarify this assumed possibility.  402 
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Tables 521 
 522 
Table 1 Antibacterial effects of inhibitory substances produced by 523 
Pseudoalteromonas aurantia NCIMB 2052T and Pseudoalteromonas citrea 524 
NCIMB 1889T upon selected bacterial strains. 525 
 526 
Microbial strain Growth 
medium 
Zones of inhibition (mm)a 
  P. aurantia 
NCIMB 2052T 
P. citrea 
NCIMB 1889T 
Nosocomial strain    
Enterococcus faecalisb LB 2 2 
Methicillin-resistant Staphylococcus aureusb LB 14 12 
Staphylococcus epidermidisb LB 16 14 
 
Laboratory strain 
Bacillus subtilis ATCC 6051T 
 
 
LB 
 
 
0 
 
 
0 
Escherichia coli K12 LB 4 2 
Escherichia coli UM255  
(catalase negative mutant) LB 20 20 
Cupriavidus metallidurans DSM 2839T LB 10 10 
Pseudoalteromonas aurantia NCIMB 2052T ASW 18 20 
Pseudoalteromonas citrea NCIMB 1889T ASW 16 19 
Pseudomonas fluorescens ATCC 13525T LB 16 16 
Saccharomyces pastorianus DSM 6580NT MYG (8)c 0 
 527 
a Mean diameters of inhibition zones were quantified by subtracting the diameter of 528 
the well (6 mm). Tests were performed in quadruplicate 529 
b clinical isolate, Molzym GmbH, Bremen 530 
c
 Partial inhibition 531 
 532 
Table 2 Effect of selected enzymes on antibacterial activity of inhibitory substances 533 
produced by Pseudoalteromonas aurantia NCIMB 2052T and Pseudoalteromonas 534 
citrea NCIMB 1889T. 535 
  536 
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Tested enzyme Effect of enzymea 
 P. aurantia 
NCIMB 2052T 
P. citrea 
NCIMB 1889T 
-Amylase -b - 
Catalase +b + 
Peroxidase + + 
Proteinase K + + 
Trypsin - - 
 537 
a Agar diffusion tests were performed using the catalase negative mutant Escherichia 538 
coli UM255 as target organism 539 
b
 Antibacterial activity: - = not neutralised; + = neutralised 540 
 541 
Figure legends 542 
 543 
Fig. 1. Production of inhibitory substances during growth of Pseudoalteromonas 544 
aurantia NCIMB 2052T (A) and Pseudoalteromonas citrea NCIMB 1889T (B) under 545 
standard incubation conditions (26 respectively 21°C at 150 rpm). Agar diffusion 546 
tests were performed using the catalase negative mutant Escherichia coli UM255 as 547 
target organism. 548 
a
 Mean diameters of inhibition zones were quantified by subtracting the diameter of 549 
the well (6 mm) 550 
 551 
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 552 
 553 
 554 
 555 
 556 
 557 
 558 
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Fig. 2. Production of inhibitory substances during growth of Pseudoalteromonas 559 
aurantia NCIMB 2052T (A) and Pseudoalteromonas citrea NCIMB 1889T (B) in 560 
dependence on temperature without shaking. Agar diffusion tests were performed 561 
using the catalase negative mutant Escherichia coli UM255 as target organism. 562 
a
 Mean diameters of inhibition zones were quantified by subtracting the diameter of 563 
the well (6 mm) 564 
 565 
 566 
 567 
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 568 
 569 
Fig. 3. Antibacterial activity of samples derived from isoelectric precipitation with 570 
culture supernatants of Pseudoalteromonas aurantia NCIMB 2052T (A) and 571 
Pseudoalteromonas citrea NCIMB 1889T (B). Agar diffusion tests were performed 572 
using the catalase negative mutant Escherichia coli UM255 as target organism. 573 
C = control with 0.03% H2O2. Numbers = pH values. 574 
 575 
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Fig. 4. Stability of inhibitory substances produced by Pseudoalteromonas aurantia 576 
NCIMB 2052T and Pseudoalteromonas citrea NCIMB 1889T at different temperatures 577 
(A) and at different pH values (B). Agar diffusion tests were performed using 578 
S. epidermidis (clinical isolate, Molzym GmbH, Bremen) as target organism. 579 
a
 Mean diameters of inhibition zones were quantified by subtracting the diameter of 580 
the well (6 mm) 581 
 582 
 583 
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Abstract 26 
 27 
Inhibitory substances produced by Pseudoalteromonas aurantia NCIMB 2052T and 28 
Pseudoalteromonas citrea NCIMB 1889T were examined. The results clearly indicate 29 
that these substances are L-amino acid oxidases (L-AAOs), which are resistant to 30 
SDS as well as to ß-mercaptoethanol when used in concentrations typical for 31 
application during SDS-PAGE. In-gel detection of the L-AAOs using non-denaturing 32 
SDS-PAGE linked with antibacterial assays reveals that P.aurantia is most probably 33 
producing three of these enzymes with molecular masses of 60-65, 225-230, and 34 
>260 kDa, whereas P. citrea is producing only two with molecular weights of 165-170 35 
and 225-230 kDa. The enzymes of P.aurantia and P. citrea show high to good 36 
hydrogen peroxide producing activities with 11 respectively 10 L-amino acids as 37 
substrates (see Fig. 4). Thus, these L-AAOs have certainly broad substrate spectra. 38 
 39 
Keywords: L-Amino acid oxidase, antibacterial activity, non-denaturing SDS-PAGE, 40 
Pseudoalteromonas aurantia, Pseudoalteromonas citrea41 
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1. Introduction 42 
 43 
An overview about the history, physiological features, and ecological significance of 44 
the genus Pseudoalteromonas was recently given by Bowman [1]. According to this 45 
review, the genus Pseudoalteromonas contains numerous marine species 46 
synthesizing biologically active substances which act upon a variety of target 47 
organisms. This seems to be a unique characteristic for this genus and may greatly 48 
benefit Pseudoalteromonas cells in their competition for nutrients and colonisation of 49 
habitats. Many members of this genus are producing bioactive substances of low 50 
and high molecular weight with antimicrobial, anti-fouling, algicidal, and various 51 
pharmaceutically-relevant activities [1]. Pseudoalteromonas aurantia NCIMB 2052T 52 
and Pseudoalteromonas citrea NCIMB 1889T are also known to produce polyanionic 53 
antibiotics [2,3], but their exact substantial and functional nature is still remaining 54 
unknown. 55 
L-Amino acid oxidases (L-amino acid: O2 oxidoreductase (deaminating), EC 1.4.3.2., 56 
L-AAO) are flavoenzymes catalysing the oxidative deamination of L-amino acids to 57 
the respective -keto acids with the release of ammonium and hydrogen peroxide [4] 58 
which determines the antimicrobial property of L-AAOs [5]. The enzyme is widely 59 
distributed in snake [6,7] and insect venoms [8] but also in algal [9], bacterial [10,11], 60 
cyanobacterial [12], fungal [13], gastropodal [14], and vertebratal sources [15,16].  61 
L-AAOs have been described also for some members of the genus 62 
Pseudoalteromonas such as P. flavipulchra [17], P. luteoviolacea [18,19], and 63 
P. tunicata [20,21]. These kinds of compounds have been reported as antitumor 64 
[8,13] as well as bacteriostatic and bacteriocidal agents [14]. It is speculated that 65 
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L-AAOs might be also involved in the amino acid metabolism and the utilization of 66 
ammonia as a nitrogen source [22,23]. L-AAOs can be differentiated into enzymes 67 
with a more strict substrate specificity [24] and into those which have a broader 68 
spectrum [19]. They typically have a dimeric structure. FAD is the cofactor of L-AAOs 69 
and binds strongly but not covalently to the protein. A main commercial application 70 
for L-AAOs is the production of D-amino acids by enzymatic resolution of racemic 71 
amino acid solutions [25,26].  72 
 73 
The aim of the present study was to elucidate the structural and functional nature of 74 
the inhibitory substances produced by P. aurantia NCIMB 2052T and P. citrea 75 
NCIMB 1889T by investigating the mechanism of inhibition, the possible substrate 76 
spectra, and the approximate molecular weights and number of these substances. 77 
 78 
2. Materials and Methods 79 
 80 
2.1 Bacterial strains and culture conditions 81 
 82 
P. aurantia NCIMB 2052T and P. citrea NCIMB 1889T were cultivated using artificial 83 
sea water (ASW), modified after Kester et al. [27]. The medium contained (l-1 distilled 84 
water) 5.0 g Casamino acids, 1.0 g yeast extract, 1.0 g glucose, 17.54 g NaCl, 85 
18.49 g MgSO4·7H2O, 1.12 g KCl, 2.21 g CaCl2·2H2O, 150.0 mg KBr, 50.0 mg 86 
Fe(III) citrate, 10.0 mg KH2PO4 (pH 7.5). Solid ASW contained (l-1 distilled water) 87 
15.0 agar, additionally. The culture medium was adjusted to pH 7.6. In dependence 88 
of the assay to be performed and if not otherwise stated, cultivation was routinely 89 
performed at 26°C (P. aurantia) respectively 21°C (P. citrea) for 1-4 d on either solid 90 
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or in liquid ASW by shaking at 150 rpm. In the latter case, an OD600 of 0.1 was used 91 
to inoculate the bacterial cultures. Cultivation of the target organism and catalase 92 
negative mutant E. coli UM255 [28] was routinely performed at 37°C using LB as 93 
described for the Pseudoalteromonads. Microorganisms were maintained at -80°C in 94 
appropriate medium with 30% (v/v) glycerol. 95 
 96 
2.2 Preparation of concentrated supernatants 97 
 98 
P. aurantia and P. citrea were grown in 1 l ASW for 24 h in 2 l Erlenmeyer flasks as 99 
described. The bacterial culture supernatants were collected by centrifugation at 100 
10,000 rpm and 4 °C for 60 min and sterile filtered. 100-fold concentration of the 101 
sterile supernatants was performed using cross-flow filtration with a cut off value of 102 
10 kDa. Storage was done by freezing at -20°C. 103 
 104 
2.3 Spectrophotometrical identification of inhibitory substances and determination of 105 
substrate spectra 106 
 107 
A modified peroxidase-coupled assay, based on the spectrophotometrical 108 
measurement of hydrogen peroxide described by Chen et al. [17], was carried out in 109 
a 1 ml cuvette with 500 μl acetone precipitated supernatants derived from P. aurantia 110 
and P. citrea cultures per standard assay mixture test (final volume: 1 ml). Acetone 111 
precipitation was performed by adding 5 volumes ice-cold acetone to 20 ml culture 112 
supernatant each and homogenised by gentle shaking. The mixtures were stored for 113 
24 h at -20 °C before centrifugation (4,000 x g, 4 °C, 30 min). The pellets were 114 
resuspended in 20 ml distilled water each.  115 
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 116 
2.4 Effect of SDS and ß-mercaptoethanol on inhibitory substances  117 
 118 
Sterile-filtrated, 100-fold concentrated culture supernatants derived from both 119 
Pseudoalteromonas strains were exposed to SDS (0.01, 0.1, 1, 2%; final 120 
concentrations), SDS plus ß-mercaptoethanol (1.5 respectively 4%; final 121 
concentrations) as well as 1-fold concentrated sample buffer (0.0625 M Tris-HCl, 122 
pH 6.8, 1.5% SDS, 4% ß-mercaptoethanol, 10% glycerol, and 0.01% bromophenol 123 
blue; final concentrations). The initial concentration of the concentrated supernatants 124 
was divided by half trough mixing with the above mentioned solutions. The resultant 125 
solutions were used in agar diffusion tests, based on the method described by Bauer 126 
et al. [29] with the following modifications. Circular wells with a diameter of 6 mm 127 
were cut into the surface of an LB agar plate. Approximately 15 ml agar medium 128 
were used per plate. Culture of the target organism E. coli UM255 (60 μl; 129 
OD600 = 0.1) was plated onto the agar surface using a Drigalski spatula. 50 μl of the 130 
different solutions respectively control were added into the wells, and zones of 131 
inhibition were determined after 24 h of incubation at 37 °C. SDS (0.01, 0.1, 1, 2%), 132 
SDS plus ß-mercaptoethanol (1.5 respectively 4%), 1-fold concentrated sample 133 
buffer, 50-fold concentrated culture supernatants, and a 0.03% H2O2 solution were 134 
used as different controls. Mean diameters of inhibition zones were quantified by 135 
subtracting the diameter of the well (6 mm). 136 
 137 
2.5 Determination of number and molecular weights of inhibitory substances 138 
 139 
2.5.1 Ultrafiltration by using different pore sizes 140 
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 141 
An initial volume of 15 ml sterile filtrated culture supernatants of P. aurantia and 142 
P. citrea each was subjected to a sequence of several pressure filtration runs using 143 
ultrafiltration units (Amicon), beginning with the largest pore size. The different cut-off 144 
values were 10, 30, 50, and 100 kDa. Centrifugation steps were performed at 145 
4,000 x g and 4 °C for 20 min. Each time, the concentrate as well as 150 μl of the 146 
flow-trough were collected and stored at 4 °C until usage. The remaining of the flow-147 
trough was subjected to another ultrafiltration unit with the next smaller pore size and 148 
centrifuged again. This procedure was repeated until the smallest pore size with a 149 
cut-off value of 10 kDa was reached, resulting overall in 8 fractions (4 times each 150 
concentrate respectively flow-through) of different kDa ranges (see Fig. 3). These 151 
fractions were used in agar diffusion tests, which were performed as described, 152 
except that the target organism was not plated onto the solid agar, because the LB 153 
agar medium had been pre-inoculated with an OD600 of 0.001. These plates were 154 
stored at most for 7 d. 155 
 156 
2.5.2 In-gel detection of inhibitory substances using SDS-PAGE linked with 157 
antibacterial assays 158 
 159 
SDS-PAGE and in-gel detection of inhibitory substances were performed as 160 
described previously [30] with the following modifications: i) 100-fold concentrated 161 
culture supernatants derived from both Pseudoalteromonas strains were used, ii) the 162 
stacking gel had an acrylamide concentration of 4% and the separation gel of 6%, 163 
respectively, iii) the Spectra™ Multicolor Broad Range Protein Ladder (Fermentas) 164 
was used for the protein standards, iv) the Coomassie-stained lane was not treated 165 
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with the modified assay mixture solution, whereas the first non-stained lane was 166 
treated, and v) the second non-stained lane was placed onto an LB agar plate 167 
containing the catalase negative mutant E. coli UM255 (OD600: 0.001) as target 168 
organism and incubated at 37 °C for 24 h to detect possible inhibitory activities of the 169 
protein bands. 170 
 171 
All tests were performed in duplicates. 172 
 173 
3. Results and Discussion 174 
 175 
3.1 Identification and functional characterisation of inhibitory substances 176 
 177 
The inhibitory substances produced by P. aurantia and P. citrea seem to have a 178 
relatively broad substrate spectrum (Fig. 4). A significant production of hydrogen 179 
peroxide could be detected with concentrated culture supernatants of both 180 
organisms when the L-amino acids Met, Leu, Gln, Phe, Tyr, Lys, Arg, His, Trp, Ala, 181 
and Asn were added as sole substrates. As can be seen in Fig. 1, the H2O2 182 
production was always weaker with the supernatant of P. citrea. Using L-Gln as 183 
substrate, it could be shown that the H2O2 production was high only with the culture 184 
supernatant of P. aurantia, while it was less than the control with the one from 185 
P.citrea. When the D-amino acids Met, Leu, and Lys were used as substrates, the 186 
H2O2 production was clearly weaker than that of the substances alone (data not 187 
shown). Therefore, the inhibitory substances produced by P. aurantia and P. citrea 188 
are actually L-AAOs with broad substrate spectra.  189 
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L-AAOs from other species of the genus Pseudoalteromonas are described to have 190 
either relatively low substrate specificity [17,19], or a very high one [20,21]. 191 
Comparing the substrate spectra of the L-AAOs produced by P. flavipulchra strain 192 
C2 [17] and strains of P. luteoviolacea [19] with those from P. aurantia and P. citrea, 193 
a lot of similarities can be found. The L-amino acids Met, Leu, Gln, Tyr, Phe, Trp, 194 
and Lys served nearly in all cases as substrates for the L-AAOs produced by the 195 
mentioned organisms. 196 
 197 
3.2 Substantial characterisation of inhibitory substances 198 
 199 
As can be seen clearly in Figure 2 A and B, the antibacterial activity of 50-fold 200 
concentrated supernatant from P. aurantia was not significantly affected in 201 
dependence on different SDS-concentrations (0.01-2%; Fig. 2 A) as well as by a 202 
combination of SDS (1.5%) plus ß-mercaptoethanol (4%) and by 1-fold concentrated 203 
sample buffer, respectively (Fig. 2 B, I and III). Use of both latter mentioned solutions 204 
showed only weak inhibition (Fig. 2 B, II and IV) which was unambiguously weaker 205 
than that of both solutions together with concentrated supernatant (Fig. 2 B, 206 
I and III). In all these approaches, the antibacterial activity was similar to that of 207 
untreated 50-fold concentrated supernatant from P. aurantia alone (data not shown). 208 
Growth of the target organism E. coli UM255 was not influenced when only SDS was 209 
used in the same concentrations as controls (data not shown). Similar results as 210 
described for P. aurantia were also obtained with P. citrea (data not shown). 211 
 212 
The obtained data have shown that the antibacterial activity of the inhibitory 213 
enzymes produced by P. aurantia and P. citrea is relatively resistant to SDS as well 214 
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as ß-mercaptoethanol. This is in accordance to results reported by Chen et al. 215 
[11,17]. The authors found the activities of antibacterial proteins from Rheinheimera 216 
sp. strain GR5 respectively P. flavipulchra strain C2 to be resistant to SDS as well as 217 
ß-mercaptoethanol (final concentrations 1% each). 218 
 219 
Culture supernatants derived from both Pseudoalteromonas strains were applied to 220 
a sequence of ultrafiltration runs in order to determine the approximate molecular 221 
weights and number of their inhibitory substances. The resultant fractions were used 222 
in agar diffusion tests. As illustrated in Figure 3 A, antibacterial activity was found in 223 
three concentrated fractions (>100, >30 <50, and >50 <100 kDa in order of 224 
descending activities) from the supernatant of P. aurantia, but only in one of that 225 
from P. citrea (>100 kDa; see Fig. 3 B). None of the flow-through fractions (not 226 
concentrated) exhibited antibacterial activity, even when the corresponding 227 
concentrated ones showed activity. Most probably too low inhibitory substance 228 
concentrations in the not concentrated fractions were the reason for these findings. 229 
High molecular weights of produced inhibitory substances have also been reported 230 
for other species of the genus Pseudoalteromonas [17-20,31,32].  231 
 232 
Non-denaturing SDS-PAGE was used to maintain enzymatic activity and to estimate 233 
the approximate number and molecular weights of the inhibitory enzymes 234 
investigated in the present study. Using Coomassie brilliant blue staining, the main 235 
proteins, present in sterile-filtrated, 100-fold concentrated culture supernatants 236 
derived from P. aurantia and P. citrea, were detected (Fig. 4 A and B). Coloured 237 
versions of the figures are accessible as supplementary material (Supplementary 238 
Fig. S1, available in EMT Online). 239 
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The bands of antibacterial as well as H2O2 producing activity and the corresponding 240 
Coomassie-stained protein bands on SDS-PAGE from P. aurantia were present in 241 
the range i) between 60-65 kDa, ii) between 225-230 kDa, and iii) larger than 242 
260 kDa in size (Fig. 4 A), while corresponding bands of P. citrea were found in 243 
ranges between i) 165-170 kDa and ii) 225-230 kDa in size (Fig. 4 B). Thus, the 244 
inhibitory substances produced by P. aurantia and P. citrea are L-AAOs with high 245 
molecular weights. 246 
This is in agreement with several reports concerning other L-AAO producing strains 247 
from the genus Pseudoalteromonas. Gómez et al. [19] also found the antimicrobial 248 
macromolecules synthesised by 3 different P. luteoviolacea strains to be L-AAOs 249 
and estimated a molecular weight of approximately 110 kDa for the L-AAO of strain 250 
CPMOR-2, while Chen et al. [17] reported a molecular mass of 60 kDa for the L-AAO 251 
of P. flavipulchra strain C2. P. tunicata strain D2 is also known to produce a 190 kDa 252 
L-AAO [20,21].  253 
Additionally, the L-AAOs produced by P. aurantia and P. citrea also have been 254 
investigated using size exclusion chromatography (SEC) via fast protein liquid 255 
chromatography (FPLC). The resulting fractions were examined for antibacterial 256 
activity using tryptic soy agar (TSA) to pour the plates and Staphylococcus 257 
epidermidis as target organism, revealing that P. aurantia is producing 3 L-AAOs of 258 
approximately 100, 240, and 480 kDa in size (data not shown). These findings are 259 
mainly in accordance with the results obtained in the SDS-PAGE study, whereby 260 
P. aurantia is also producing 3 L-AAOs (see above). Gauthier and Breittmayer [3] 261 
reported only the presence of one polyanionic inhibitory substance produced by 262 
P. aurantia. 263 
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For P. citrea, the SEC together with the tested antibacterial activity showed that only 264 
one L-AAO of approximately 120 kDa in size was produced (data not shown). This is 265 
in contrast to the SDS-PAGE study, where P. citrea was producing 2 L-AAOs (see 266 
above). Using an electrophoresis setup with Cellogel strips, Gauthier [2] also found 267 
2 different polyanionic inhibitory substances for P. citrea. Two facts might be 268 
considered to explain the differences between the results of the SDS-PAGE and 269 
SEC studies as well as those obtained by Gauthier [2] and by Gauthier and 270 
Breittmayer [3]. First, Staphylococcus epidermidis was used as target organism for 271 
the agar diffusion tests with fractions obtained during SEC, by Gauthier [2] and by 272 
Gauthier and Breittmayer [3]. This organism is less sensitive to the inhibitory 273 
enzymes produced by P. aurantia and P. citrea (data not shown), in comparison to 274 
the catalase negative mutant E. coli UM255, which was used for the SDS-PAGE 275 
study. Second, tryptic soy agar (TSA) was used for the agar diffusion tests during the 276 
SEC study, by Gauthier [2] and by Gauthier and Breittmayer [3], instead of LB, which 277 
was used for the SDS-PAGE study. It is known that the type and the amount of 278 
amino acids present in the incubation medium influence the activity level of L-AAOs 279 
[11,17,19]. Thus, both mentioned characteristics might be an explanation for the 280 
difference in the number of inhibitory enzymes obtained with the in-gel assays after 281 
SDS-PAGE and by SEC in the present study as well as reported by Gauthier [2] and 282 
by Gauthier and Breittmayer [3]. 283 
 284 
To prove that the L-AAOs from P. aurantia of high molecular weights (225-230 and 285 
>260 kDa) might be polymers of the 60-65 kDa L-AAO, acetone-precipitated 100-fold 286 
concentrated culture supernatant was subjected to a 100 kDa ultrafiltration unit 287 
(Amicon) to separate the 60-65 kDa L-AAO from the others. Both fractions obtained 288 
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were then undergone the described peroxidase-coupled assay. The results showed 289 
that the substrate spectra of both fractions are nearly identical (see Supplementary 290 
Fig. S2, available in EMT Online).  291 
From these observations, it can be assumed that P. aurantia does not produce 292 
3 different L-AAOs but only one structural unit of 60-65 kDa in size. The 293 
225-230 kDa substance is possibly a tetramer of the 60-65 kDa unit, whereas the 294 
substance >260 kDa, respectively 480 kDa with regard to the results obtained by 295 
SEC, might be the corresponding octamer. This assumption is supported by findings 296 
with respect to isoelectric point studies of the inhibitory substances from P. aurantia. 297 
We found out that only the precipitate derived from pH 8.7 had inhibitory activity, but 298 
none of the fractions obtained at other pH values (data not shown). In addition, if the 299 
100-fold concentrated culture supernatant of P. aurantia was incubated together with 300 
sample buffer for 30 min at various temperatures (20, 40, 50, and 60°C) before 301 
performing SDS-PAGE, it could be demonstrated that the bands corresponding to 302 
L-AAOs of 225-230 and >260 kDa in size clearly disappeared before that of the 303 
60-65 kDa L-AAO (see Supplementary Fig. S3, available in EMT Online). Both of 304 
these findings (isoelectric points and temperature treatment) contribute to the 305 
hypothesis of the occurrence of only one structural unit of 60-65 kDa in size with 306 
inhibitory activity. This assumption is additionally supported by studies on the green 307 
microalga Chlamydomonas reinhardtii strains CW15, a class-C mutant characterised 308 
by the absence or greatly reduced quantity of cell wall compared to wildtype cells. 309 
Piedras et al. [33] found the L-AAO of the mentioned strain to have a molecular 310 
weight of ~470 kDa, consisting of eight identical or similarsized subunits of ~60 kDa 311 
each, as also speculated in the present study for the L-AAO of P. aurantia. Vallon 312 
et al. [34] investigated strain CW15 as well and described an L-AAO of  313 
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~900-1000 kDa and another form of ~1200-1300 kDa, consisting of ~13-16 identical 314 
subunits of 66 kDa in size (with L-AAO activity), and, in the case of the heavier form, 315 
additionally of 3-4 copies of a 135 kDa polypeptide (without L-AAO activity). If the  316 
L-AAO reported by Piedras et al. [33] is part of the L-AAO found by Vallon et al. [34] 317 
or if both are different enzymes sharing some similar properties, could not be 318 
clarified [34]. 319 
 320 
 4. Conclusions 321 
 322 
In the present study it could be shown that the antibacterial activity of the inhibitory 323 
substances produced by P. aurantia and P. citrea is maintained during treatment 324 
with SDS as well as ß-mercaptoethanol when used in concentrations typical for 325 
application during SDS-PAGE. The results of the in-gel detection of inhibitory 326 
substances using non-denaturing SDS-PAGE linked with antibacterial assays have 327 
indicated that P.aurantia is most probably producing three inhibitory substances  328 
(60-65, 225-230, and >260 kDa) and P. citrea two (165-170, 225-230 kDa). Further 329 
on, it can be assumed that the three inhibitory substances of P. aurantia might be all 330 
composed of one structural unit of 60-65 kDa in size. Due to the specificity of the 331 
used H2O2 detecting assay, it could be clearly shown that the inhibitory substances 332 
of P. aurantia and P. citrea are L-AAOs whose antibacterial activities are caused by 333 
the production of H2O2 in the presence of appropriate amino acids. These L-AAOs 334 
had broad substrate spectra. When comparing the L-AAO spectra of both organisms, 335 
it could be shown that there are some differences, but generally both spectra are 336 
rather similar. Thus, it could be presumed that the structure of the active parts of the 337 
L-AAOs might be identical, supported by findings concerning other 338 
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Pseudoalteromonas species [17,19]. It would be desirable to gain more information 339 
about the L-AAOs produced by P. aurantia, P. citrea, and other Pseudoalteromonads 340 
due to their possible use in antibiotic therapy as well as in the biotechnological field.    341 
 342 
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Figure legends 481 
 482 
Fig. 1. Hydrogen peroxide production (ppm) formed in a peroxidase-coupled assay 483 
with acetone-precipitated culture supernatants of P. aurantia NCIMB 2052T and 484 
P. citrea NCIMB 1889T depending on the L-amino acid added. Further details are 485 
given in material and method section. Control without any amino acid, C. 486 
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 489 
Fig. 2. Influence of SDS,  ß-mercaptoethanol, and sample buffer on the antibacterial 490 
activity of 50-fold concentrated culture supernatant of P. aurantia NCIMB 2052T. 491 
A: Antibacterial activity in dependence on different SDS-concentrations. 492 
B: Antibacterial activity in the presence of (I) 1.5% SDS plus 4% ß-mercaptoethanol 493 
and (III) 1-fold concentrated sample buffer (see Materials and Methods). 494 
II and IV: Same solutions as in (I) respectively (III) but without concentrated culture 495 
supernatant. Agar diffusion tests were performed using the catalase negative mutant 496 
Escherichia coli UM255 as target organism. 0.03% H2O2 served as control, C. 497 
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 498 
 499 
Fig. 3. Antibacterial activity in fractions (concentrate respectively flow-through) of 500 
different molecular weights obtained by using a sequence of ultrafiltration runs from 501 
culture supernatants of P. aurantia NCIMB 2052T (A) and P. citrea NCIMB 1889T (B). 502 
Agar diffusion tests were performed using the catalase negative mutant Escherichia 503 
coli UM255 as target organism. Further details are given in the material and method 504 
section. 0.03% H2O2 served as control, C. Numbers refer to kilodalton (kDa). 505 
Concentrated fractions are marked (+). 506 
 507 
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Fig. 4. SDS-PAGE and 2 different in-gel assay techniques for detecting H2O2 508 
production and antibacterial activity of 100-fold concentrated culture supernatants 509 
from P. aurantia NCIMB 2052T (A) and P. citrea NCIMB 1889T (B). Triplicate lanes 510 
loaded with identical non-heated samples were handled separately after gel 511 
electrophoresis. Lane I: stained with CBB. Lane II: in-gel detection of the inhibitory 512 
substances using the H2O2 detecting assay. Lane III: inhibitory plate test on LB agar 513 
with the catalase negative mutant E. coli UM255 as target organism (zones of 514 
inhibition were visualised). M: molecular masses (kDa) of standard proteins 515 
(Spectra™ Multicolor Broad Range Protein Ladder; Fermentas). Coloured versions 516 
of the figures are accessible as supplementary material (Supplementary Fig. S1, 517 
available in EMT Online). 518 
 519 
 520 
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Fig. S1. SDS-PAGE and 2 different in-gel assay techniques for detecting H2O2 521 
production and antibacterial activity of 100-fold concentrated culture supernatants 522 
from P. aurantia NCIMB 2052T (A) and P. citrea NCIMB 1889T (B). Triplicate lanes 523 
loaded with identical non-heated samples were handled separately after gel 524 
electrophoresis. Lane I: stained with CBB. Lane II: in-gel detection of the inhibitory 525 
substances using the H2O2 detecting assay. Lane III: inhibitory plate test on LB agar 526 
with the catalase negative mutant E. coli UM255 as target organism (zones of 527 
inhibition were visualised). M: molecular masses (kDa) of standard proteins 528 
(Spectra™ Multicolor Broad Range Protein Ladder; Fermentas). 529 
 530 
 531 
 532 
 533 
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Fig. S2. Hydrogen peroxide production (ppm) formed in a peroxidase-coupled assay 534 
with fractions containing the inhibitors of either 60-65 or 225-230 kDa in size derived 535 
from acetone-precipitated 100-fold concentrated culture supernatant of P. aurantia 536 
NCIMB 2052T depending on the L-amino acid added. Further details are given in the 537 
material and method section. Control without any amino acid, C. 538 
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 541 
Fig. S3. SDS-PAGE and in-gel assay technique for detecting H2O2 producing activity 542 
of 100-fold concentrated culture supernatant from P. aurantia NCIMB 2052T after 543 
having been incubated for 30 min at different temperatures. Samples applied were 544 
incubated together with 1-fold concentrated sample buffer (see Materials and 545 
Methods). 546 
 547 
                                                                                                                  Manuscript II 
 88
 548 
 549 
                                                                                                                 Manuscript III 
 89
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Manuscript III 
 
3.3 L-lysine oxidase: an inhibitory substance produced by the marine 
filamentous cyanobacterium Geitlerinema strain Flo1 
 
 
 
 
 
 
 
 
                                                                                                                 Manuscript III 
 
90 
Running title:  1 
L-lysine oxidase from Geitlerinema strain Flo1 2 
 3 
Title: 4 
L-lysine oxidase: an inhibitory substance produced by the marine filamentous 5 
cyanobacterium Geitlerinema strain Flo1 6 
 7 
Jan Peter Schrübbersa 8 
Jan Erik Raua 9 
Ulrich Fischera 10 
 11 
aZentrum für Umweltforschung und nachhaltige Technologien, Fachbereich 12 
Biologie/Chemie, Abteilung Marine Mikrobiologie, Universität Bremen, Leobener 13 
Straße, D-28359 Bremen, Germany 14 
 15 
Corresponding author: 16 
Jan Erik Rau  17 
Tel.: +49- (0) 421-218-63409 18 
Fax: +49- (0) 421-218-7222 19 
Email: jerau@uni-bremen.de 20 
 21 
                                                                                                                 Manuscript III 
        91 
Abstract 22 
 23 
An inhibitory substance is secreted by the marine filamentous cyanobacterial strain 24 
Flo1 which inhibits the growth of several microorganisms. The inhibitory effect of 25 
culture supernatant derived from strain Flo1 is caused by an L-amino acid oxidase 26 
(L-AAO). The enzyme shows high hydrogen peroxide producing activity only with the 27 
substrate L-lysine and can therefore be regarded as an L-lysine oxidase. This 28 
enzyme uses L-lysine, oxygen, and water as substrates resulting in the respective 29 
-keto acid with the release of ammonium and hydrogen peroxide. In-gel detection of 30 
the enzyme using non-denaturing SDS-PAGE linked with antibacterial assays 31 
reveals that strain Flo1 produces an L-lysine oxidase with an approximate molecular 32 
weight of 55 kDa. Phylogenetic studies show that strain Flo1 is taxonomically most 33 
closely related to the genus Geitlerinema. However, the closest relative of strain Flo1 34 
at 16S rDNA level, Geitlerinema strain PCC 7105, does not produce a substance of 35 
this kind. This is the first report of a marine cyanobacterium using an L-lysine 36 
oxidase for generating hydrogen peroxide that inhibits microbial growth.  37 
 38 
Keywords: Antibacterial activity, Geitlerinema strain Flo1, L-lysine oxidase, non-39 
denaturing SDS-PAGE 40 
 41 
Abbreviations: L-amino acid oxidase (L-AAO); Artificial seawater of half salinity 42 
supplemented with nitrate (ASN III/2) 43 
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Introduction 44 
 45 
The marine filamentous cyanobacterial strain Flo1 has been studied recently due to 46 
its high biotechnological potential. This organism produces and secretes at least one 47 
biologically active substance into the environment which inhibits growth of the yeast 48 
Saccharomyces cerevisiae, of several heterotrophic marine bacteria as well as of 49 
fungi (Heyduck-Söller and Fischer, 2000; Caicedo et al., 2010). However, the 50 
substance has not been identified so far by the mentioned studies. Additionally, 51 
strain Flo1 has been used as model organism for quantitative analysis of 52 
bioproduction of antimicrobial compounds (Caicedo et al., 2010). 53 
Cyanobacteria are commonly known as effective producers of secondary 54 
metabolites of biotechnological and pharmaceutical interest. Many different products 55 
with a broad range of biological activity have been reported (Burja et al., 2001). 56 
These substances can have toxic, antibacterial, antiviral, fungicide, 57 
immunosuppressive, and enzyme inhibiting activities (Burns et al., 2005).  58 
A further class of bioactive substance with allelopathic effects are the L-amino acid 59 
oxidases (L-amino acid: O2 oxidoreductase (deaminating), EC 1.4.3.2., L-AAO). 60 
L-AAOs are flavoenzymes catalysing the oxidative deamination of L-amino acids to 61 
the respective -keto acids with the release of ammonium and hydrogen peroxide 62 
(Wellner and Meister, 1961) which determines the antimicrobial property of L-AAOs 63 
(Stiles et al., 1991). The enzyme is widely distributed in snake (Du and Clemetson, 64 
2002; Alves et al., 2008) and insect venoms (Ahn et al., 2000) but also in algal 65 
(Fujisawa et al., 1982), bacterial (Tong et al., 2008; Chen et al., 2010a), 66 
cyanobacterial (Gau et al., 2007), fungal (Kusakabe et al., 1980), gastropodal (Yang 67 
et al., 2005), and vertebratal sources (Sun et al., 2002; Kasai et al., 2010). L-AAOs 68 
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have been reported as antitumor (Kusakabe et al., 1980; Ahn et al., 2000) as well as 69 
bacteriostatic and bacteriocidal agents (Yang et al., 2005). L-AAOs can be 70 
differentiated into enzymes with a more strict substrate specificity (Lucas-Elío et al., 71 
2006) and into those which have a broader spectrum (Gómez et al., 2008). They 72 
typically have a dimeric structure. FAD is the cofactor of L-AAOs and binds strongly 73 
but not covalently to the protein. A main commercial application for L-AAOs is the 74 
production of D-amino acids by enzymatic resolution of racemic amino acid solutions 75 
(Parikh et al., 1958; Takahashi et al., 1997). 76 
The aim of the present study was i) to elucidate the structural and functional nature 77 
of an inhibitory substance produced by the marine filamentous cyanobacterial strain 78 
Flo1 by investigating the mechanism of inhibition, the possible substrate spectrum, 79 
and the approximate molecular weight of this substance as well as ii) to analyse the 80 
phylogenetic position of strain Flo1 amongst closely related cyanobacteria. As a 81 
reference, the same experiments were performed with Geitlerinema strain 82 
PCC 7105, the closest relative to strain Flo1. 83 
 84 
Material and methods  85 
 86 
Culture and growth conditions 87 
 88 
Strain Flo1 was originally isolated from a mangrove wood in Florida near Key 89 
Biscane and cultivated in the culture collection of the Department of Marine 90 
Microbiology at the University of Bremen (Germany). The reference strain 91 
Geitlerinema PCC 7105 was provided by the Pasteur Culture Collection (Paris, 92 
France). Both strains were axenic, as proven by light microscopy. Organisms were 93 
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cultivated for 3 to 4 weeks in glass-columns (52 cm length and 5 cm in diameter, 94 
closed by a rubber stopper) containing 600 ml of artificial seawater of half salinity 95 
supplemented with nitrate (ASN III/2; modified after Rippka et al., 1979). The 96 
medium contained (l-1 distilled water) 12.5 g NaCl,1.0 g MgCl2·6H2O, 0.25 g 97 
KCl,1.75 g MgSO4·7H2O, 0.25 g CaCl2·2H2O, 0.75 g NaNO3, 0.12 g Na2CO3, 0.01 g 98 
K2HPO4·H2O, 1.5 mg Fe-NH4-citrate, 5 mg vitamin B12, and 0.5 ml of a trace metal 99 
mix solution (modified after Rippka et al., 1979). This solution contained 3.0 g 100 
Na3-citrate·2H2O, 5.0 g Na2-EDTA·2H2O, 2.86 g H3BO3, 1.81 g MnCl2·4H2O, 0.22 g 101 
ZnSO4·7H2O, 0.39 g Na2MoO4·5H2O, 0.08 g CuSO4·5H2O, and 0.05 g 102 
Co(NO3)2·6H2O. Cultures were kept under a constant photon flow density of 103 
5 μE m-2 s-1 photosynthetically active radiation and a constant aeration with sterile-104 
filtered air to avoid shading and precipitating of the cells. Cells were harvested by 105 
centrifugation at 5,000 rpm for 10 min. Cultivation of the target organisms was 106 
routinely performed at the optimal growth temperature of the particular strains for 107 
1-3 d on either solid LB or MYG media or in liquid ones (see also 2.2) by shaking at 108 
120 rpm. In the latter case an OD600 of 0.1 was used to inoculate the bacterial 109 
cultures. 110 
 111 
Antibiogram assay 112 
 113 
The antibacterial potential of culture supernatant from strains Flo1 and PCC 7105 114 
were investigated using the agar diffusion test, based on the method described by 115 
Bauer and co-workers (1966) with the following modifications. Circular wells with a 116 
diameter of 6 mm were stamped into the surface of an LB agar plate (for 117 
Saccharomyces pastorianus DSM 6580NT MYG agar was used) by the upper end of 118 
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a sterile Pasteur pipette. Approximately 15 ml agar medium were used per plate. 119 
Cultures of test strains (60 μl; OD600 = 0.1) were plated onto the agar surface using 120 
a Drigalski spatula. 50 μl of sterile filtered cyanobacterial culture supernatant were 121 
added to the wells and zones of inhibition were determined after 24 h of incubation at 122 
the optimal growth temperature of the respective target organism. 50 μl 0.03% H2O2 123 
were used as a control. Mean diameters of inhibition zones were quantified by 124 
subtracting the diameter of the well (6 mm). Tests were performed in quadruplicate. 125 
Antibacterial activities of the inhibitory substance of strain Flo1 were tested by using 126 
the following organisms: Bacillus subtilis ATCC 6051T, Escherichia coli K12, catalase 127 
negative mutant Escherichia coli UM255 (Mulvey et al., 1988), Pseudomonas 128 
fluorescens ATCC 13525T, Staphylococcus epidermidis (clinical isolate, Molzym 129 
GmbH, Bremen), and the yeast Saccharomyces pastorianus DSM 6580NT. 130 
 131 
Identification of the inhibitory substance and determination of its substrate spectrum  132 
 133 
A modified peroxidase-coupled assay, based on the spectrophotometrical 134 
measurement of hydrogen peroxide was carried out as described by Chen and 135 
co-workers (2010b) in order to identify the inhibitory substance produced by strain 136 
Flo1 and to determine its substrate spectrum. 500 μl sterile filtrated culture 137 
supernatant of strain Flo1 were used in a 1 ml cuvette per standard assay mixture 138 
test (final volume: 1 ml). Tests were performed in duplicate. 139 
 140 
SDS-PAGE and in-gel antibacterial assays 141 
 142 
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SDS-PAGE and in-gel detection of inhibitory substances were performed as 143 
described previously (Rau and Fischer, 2011), but with the following modifications: 144 
37.5-fold concentrated culture supernatants derived from strains Flo1 and PCC 7105 145 
were used. The Coomassie-stained lane was not treated with the modified assay 146 
mixture solution, whereas the first non-stained lane was. The second non-stained 147 
lane was placed onto an LB agar plate containing the catalase negative mutant 148 
E. coli UM255 (OD600 0.001) as target organism and incubated at 37 °C for 24 h to 149 
detect possible inhibitory activities of the protein bands. Spectra™ Multicolor Broad 150 
Range Protein Ladder (Fermentas) was used as protein standard. The 151 
corresponding figures 3 and S1 were digitally enhanced by adjusting colour and 152 
contrast using the freeware program GIMP (version 2.6.11). 153 
 154 
DNA extraction 155 
 156 
Cells were disrupted by using N-Lauroylsarcosine (final conc. 1% for 1 h in the dark 157 
at 4 °C), lysozyme (0.5 mg/ml), SDS (final conc. 1%), and proteinase K (100 μg/ml; 158 
derived from Tritirachium album, AppliChem) for 1h at 37 °C. DNA was extracted 159 
with phenol/chloroform/isoamylalcohol (25:24:1 (v/v/v)) and precipitated with 160 
isopropanol. 161 
 162 
Amplification of 16S rDNA 163 
 164 
Amplification of 16S rDNA was performed using 2.5 mM MgCl2, 0.2 mM dNTP 165 
solution, 0.5 U polymerase (TrueStart Polymerase; Fermentas), and 0.8 μM each of 166 
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the primers 8F (AGAGTTTGATCCTGGC; Lane, 1991) and 1494R 167 
(GTACGGCTACCTTGTTACGAC; Taton et al., 2003). 168 
The PCR thermal cycle included an initial denaturation step at 95 °C for 2 min, 169 
followed by 30 cycles of denaturation at 95 °C for 30 sec, primer annealing for 170 
30 sec at 58 °C followed by a cycle extension at 72 °C for 1 min and a final extension 171 
at 72 °C for 5 min. Amplification reactions were performed using a T3 Thermocycler 172 
(Biometra). PCR products were visualised with RedSafe (iNtRON Biotechnology) on 173 
1% agarose gels. Products were purified (DNA Clean and Concentrator sample Kit; 174 
Zymo Research) and sequenced (GATC, Konstanz, Germany). 175 
 176 
Phylogenetic analysis 177 
 178 
The sequences obtained from amplification were merged together with Chromas Pro 179 
version 1.34. The closest relatives of strain Flo1 were determined by performing 180 
BLAST database searches. Subsequent analyses of the 16S rDNA sequence of the 181 
isolate, as well as of closely related sequences were performed using the ARB 182 
software package (version 5.2; Ludwig et al., 2004) and the corresponding SILVA 183 
SSURef 104 database (release October 2010; Pruesse et al., 2007). Nearly the 184 
complete 16S rDNA sequence of strain Flo1 (1,348 bp) was aligned automatically 185 
using the PT server implemented in the ARB software package and the alignment 186 
was checked manually. Phylogenetic trees were reconstructed according to the 187 
neighbour-joining (Saitou and Nei, 1987), maximum-parsimony (Fitch, 1971), and 188 
maximum-likelihood (Felsenstein, 1981) methods. The stability of the groupings was 189 
estimated by bootstrap analysis (Felsenstein, 1985) of the neighbour-joining and 190 
maximum-parsimony methods based on 1,000 replications. The 16S rDNA sequence 191 
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of strain Flo1 is deposited in the NCBI database (GenBank accession 192 
no. FJ042947). 193 
 194 
Results and discussion 195 
 196 
Antibiogram of the inhibitory substance 197 
 198 
The antibiogram showed diverse inhibitory effects on the target organisms used. 199 
Gram-negative as well as Gram-positive bacteria were affected by the culture 200 
supernatant without any purification or concentration, indicating the high potential of 201 
the inhibitory substance. In particular, the culture supernatant of strain Flo1 showed 202 
no inhibitory effect upon the yeast Saccharomyces pastorianus and upon Bacillus 203 
subtilis, whereas distinct inhibition zones of 8 to 19 mm were found with strains 204 
E. coli K12, P. fluorescens, and S. epidermidis in ascending order. The highest 205 
inhibitory effect, resulting in an inhibition zone of 22 mm, was obtained with the 206 
catalase negative mutant E. coli UM255. The supernatant of the used reference 207 
strain PCC 7105 exhibited no inhibitory effect upon none of the target organisms 208 
tested (Table 1).  209 
 210 
The inhibitory potential of substances produced by strain Flo1 was investigated 211 
previously by two other studies. Heyduck-Söller and Fischer (2000) reported that the 212 
cyanobacterial culture medium, pre-cultivated with strain Flo1 (basonym: Oscillatoria 213 
limnetica strain Flo1), showed growth inhibitory effects against the yeast 214 
Saccharomyces cerevisiae as well as against several Gram-negative and 215 
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Gram-positive bacteria, including Escherichia coli. Interestingly, these authors could 216 
not detect any inhibitory growth effect against Bacillus subtilis.  217 
Caicedo and co-workers (2010) found two different Amberlite-extracts of the culture 218 
supernatant from strain Flo1 to show respectively antifungal and antibacterial 219 
activities against several fungi as well as against B. subtilis. Both studies (Heyduck-220 
Söller and Fischer, 2000; Caicedo et al., 2010) made only minor attempts to identify 221 
the inhibitory substance(s). Caicedo and co-workers (2010) figured out that the 222 
addition of bromide ions to the culture medium resulted in a higher inhibitory activity, 223 
but only against the terrestrial bacteria tested and not against the marine bacterial 224 
strain Bo 53-31. 225 
In the present study, we found a few contrary results to the above mentioned ones 226 
regarding the antimicrobial effects of culture supernatant from strain Flo1. Compared 227 
to the findings of Caicedo and co-workers (2010), B. subtilis was not inhibited by 228 
culture supernatants of strain Flo1 in the present study and in that by Heyduck-Söller 229 
and Fischer (2000). In addition, no inhibitory effect upon yeasts from the genus 230 
Saccharomyces was observed in the present work, contrary to the previous studies 231 
(Heyduck-Söller and Fischer, 2000; Caicedo et al., 2010). These differences might 232 
be explained by the use of different approaches to determine the antimicrobial 233 
activity of the culture supernatant from strain Flo1. As in the present study, Heyduck-234 
Söller and Fischer (2000) used agar diffusion tests, but with the following 235 
differences: i) ASN III/2 agar medium supplemented with 0.1% (w/v) yeast extract 236 
was taken, ii) 1 ml of 106 cells of the respective target organism cultures was mixed 237 
with 15 ml of the agar medium, iii) paper disks were applied, and iv) only 10 μl of 238 
culture supernatant were applied. Caicedo and co-workers (2010) did not use agar 239 
diffusion tests. The authors determined the antimicrobial potential by following the 240 
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growth of the target organisms in microtiter plates by measurement of the turbidity at 241 
570 nm. Instead of untreated culture supernatant, the authors evaluated the 242 
inhibitory potential of different Amberlite-extracts derived from culture supernatant. 243 
50 μl of the respective extract were mixed with 50 μl of 104 cells of the appropriate 244 
target organism cultures per well of the microtiter plate. 245 
As shown in the present study, the growth inhibitory effect of the culture supernatant 246 
from strain Flo1 was found to be highest against the catalase negative mutant E. coli 247 
UM255. This organism lacks catalase encoding genes and, therefore, is unable to 248 
degrade present hydrogen peroxide. This indicates that catalase and, thereby, also 249 
hydrogen peroxide could play an important role in the mechanism of inhibition of one 250 
of the inhibitory substances produced by strain Flo1. However, the influence of 251 
bromide ions was not investigated in the present study. 252 
 253 
Identification and determination of the substrate spectrum  254 
 255 
The antibacterial substance derived from concentrated culture supernatant of strain 256 
Flo1 was used in a peroxidase-coupled assay with the 20 standard amino acids to 257 
identify it and to elucidate its substrates (Fig. 1). When L-lysine was offered as sole 258 
substrate, a significant production of hydrogen peroxide could be measured which 259 
was unambiguously higher than that of the compound alone. When D-lysine was 260 
used, the H2O2 production was clearly lower than that of the compound alone. 261 
Therefore, the inhibitory compound produced and excreted into the medium by strain 262 
Flo1 is actually an L-AAO with very high substrate specificity and can be regarded as 263 
L-lysine oxidase. 264 
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Regarding the presence of L-AAOs in other cyanobacteria, these enzymes, to our 265 
knowledge, have been detected so far only in the order Chroococcales and, in 266 
particular, in the Synechococcus elongatus strains PCC 6301 and PCC 7942 as well 267 
as in Synechococcus cedrorum strain PCC 6908 (Gau et al., 2007). According to the 268 
latter mentioned study, the L-AAOs produced by the particular Synechococcus 269 
strains can catalyse the oxidative deamination of basic L-amino acids 270 
(L-Arg > L-Lys > L-Orn > L-His) into their respective -keto acids, whereas other 271 
amino acids are not converted. In contrast to these observations, the L-AAO derived 272 
from strain Flo1 shows activity only with the substrate L-lysine. To our knowledge, 273 
substrate specificity restricted to only one L-amino acid was not observed for any 274 
other cyanobacterial strain so far. Therefore, the finding of the present study can be 275 
regarded as a novum concerning this kind of organisms. 276 
Furthermore, it is known that different kinds of media contain distinct types and 277 
amounts of amino acids which have an influence on the activity of L-AAOs (Gómez 278 
et al., 2008; Chen et al., 2010a,b). Caicedo and co-workers (2010) also mentioned 279 
an influence of the used growth medium on the strength of the inhibitory activity of 280 
different Amberlite-extracts derived from strain Flo1 culture supernatants. This can 281 
be regarded as additional proof that one of the inhibitory substances of Flo1 is an 282 
L-AAO. 283 
 284 
Further analysis of the antibacterial substance  285 
 286 
The antibacterial enzyme investigated in this study did not loose its inhibitory activity 287 
when in contact with SDS and ß-mercaptoethanol, hence non-denaturing 288 
SDS-PAGE was used to maintain enzymatic activity and to estimate the approximate 289 
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molecular weight of this substance. Using Coomassie brilliant blue staining, the main 290 
proteins present in sterile-filtrated, 37.5x concentrated culture supernatant derived 291 
from strain Flo1 were visualized. Two different in-gel assay techniques were applied 292 
to detect single bands of antibacterial, H2O2 producing activity which belonged to a 293 
salient protein band (Fig. 2, II). The antibacterial, H2O2 producing activity bands 294 
(Fig. 2B, II and C, II) and the corresponding stained one on SDS-PAGE (Fig. 2A, II) 295 
appeared in each case as a separate band of approximately 55 kDa in size for the 296 
L-lysine oxidase of strain Flo1. 297 
The same experiments were also performed with the reference strain Geitlerinema 298 
PCC 7105. However, this strain neither produced a 55 kDa protein in significant 299 
amounts nor gave a positive response in the H2O2-detecting assay or showed any 300 
inhibition in the antibacterial plate assay (Fig. 2, I). 301 
 302 
Gau and co-workers (2007) investigated putative L-AAOs in different cyanobacteria 303 
by evaluating 24 genomes for the presence of the aoxA gene encoding a protein with 304 
similarity to this kind of enzymes. The results revealed that in several cyanobacterial 305 
genera this gene is present, including Gloeobacter, Nostoc, Synechococcus, 306 
Synechocystis, and Trichodesmium. Furthermore, the same authors calculated 307 
possible molecular weights of 30-59 kDa (mainly 51-54 kDa) for the putative L-AAOs 308 
encoded by the aoxA gene. These results are in accordance to the findings from the 309 
present study, where a molecular weight of approximately 55 kDa for the L-AAO 310 
produced by strain Flo1 by using in-gel detection after non-denaturing SDS-PAGE 311 
was determined.  312 
Apart from that, Schriek and co-workers (2009) found Synechocystis sp. PCC 6803 313 
to produce an L-amino acid dehydrogenase of approximately 404 kDa in size. 314 
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However, compared with L-AAOs, this enzyme is not causing any production of H2O2 315 
by its activity and, thereby, has no inhibitory effects. 316 
 317 
Phylogenetic analysis  318 
 319 
Phylogenetic trees were reconstructed to give an overview of strain Flo1 and its 320 
taxonomic position amongst closely related cyanobacteria.  321 
Nearly the complete 16S rDNA sequence (1,348 bp) of Flo1 was used for an initial 322 
BLAST search against GenBank, resulting in a sequence similarity of 99.6-100.0% to 323 
Geitlerinema PCC 7105 (GenBank accession no. AB039010 and AF132780, 324 
respectively). These unambiguous sequence identities clearly demonstrate the 325 
taxonomic position of strain Flo1 within the genus Geitlerinema. The affiliation of 326 
strain Flo1 to this genus and, in particular, to Geitlerinema PCC 7105 (AB039010 327 
and AF132780) is also documented in the phylogenetic tree (Fig. 3). Strain Flo1 328 
formed a phyletic cluster together with the former mentioned strain as well as with 329 
Geitlerinema MBIC10006 (AB058204) and Geitlerinema A28DM (FJ410907). The 330 
overall tree topology was supported by all tree-making methods used in this study. 331 
However, the branching patterns varied little depending on the tree-making method 332 
used. 333 
 334 
Conclusions 335 
 336 
In the present study we report for the first time of an inhibitory effect caused by an 337 
L-AAO produced by the marine filamentous cyanobacterium Geitlerinema strain 338 
Flo1. The enzyme described in the present study shows very high substrate 339 
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specificity to L-lysine which is a novelty concerning a cyanobacterial strain. The 340 
function of the L-AAOs in the overall metabolism of cyanobacteria is still unclear 341 
(Gau et al., 2007), however, it is likely that L-AAOs are involved in the utilization of 342 
ammonia as a nitrogen source (MacHeroux et al., 2001). Additional studies are 343 
planned to gain more information about the L-lysine oxidase produced by 344 
Geitlerinema strain Flo1 concerning its possible application as an antibiotic or in 345 
biotechnology. 346 
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Tables 511 
 512 
Table 1 Antibacterial activity of cyanobacterial supernatants from strains Flo1 and 513 
PCC 7105 upon different target organisms. Zones of inhibition were determined after 514 
24 h of incubation. Further details are given in the material and method section.  515 
 516 
Microbial strain Growth 
medium 
Zones of inhibition (mm)a 
  Geitlerinema 
strain Flo1 
Geitlerinema 
strain PCC 7105 
Nosocomial strain    
Staphylococcus epidermidisb LB 19 0 
 
Laboratory strain 
Bacillus subtilis ATCC 6051T 
 
 
LB 
 
 
0 
 
 
0 
Escherichia coli K12 LB 6 0 
Escherichia coli UM255  
(catalase negative mutant) LB 22 0 
Pseudomonas fluorescens ATCC 13525T LB 14 0 
Saccharomyces pastorianus DSM 6580NT MYG 0 0 
 517 
a
 Mean diameters of inhibition zones were quantified by subtracting the diameter of 518 
the well (6 mm). Tests were performed in quadruplicate 519 
b clinical isolate, Molzym GmbH, Bremen 520 
 521 
Figure legends 522 
 523 
Fig. 1. Hydrogen peroxide production (ppm) formed in a peroxidase-coupled assay 524 
with concentrated culture supernatant of strain Flo1 in dependence of L-amino acids 525 
and D-lysine offered. Tests were performed in duplicate. C: control without any 526 
amino acid. 527 
 528 
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 529 
 530 
Fig. 2. H2O2 production and antibacterial activities exhibited by strains Geitlerinema 531 
PCC 7105 (I) and Flo1 (II) documented by SDS-PAGE (A) and two different in-gel 532 
assay techniques (Panels B and C). Triplicate lanes loaded with identical non-heated 533 
samples were handled separately after gel electrophoresis. Panel A was stained with 534 
Coomassie brilliant blue, the two others were used for in-gel detection of the 535 
inhibitory substances using an H2O2 detecting assay (B) and an inhibitory plate test 536 
on LB agar with catalase negative mutant E. coli UM255 as target organism (C). 537 
M: molecular masses (kDa) of standard proteins (Spectra™ Multicolor Broad Range 538 
Protein Ladder; Fermentas). A coloured version of the figure is accessible as 539 
supplementary material (Supplementary Fig. S1, available in EMT Online). 540 
 541 
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 542 
 543 
Fig. 3. Neighbour-joining phylogenetic tree based on 16S rDNA sequences of strain 544 
Flo1 and closely related cyanobacteria. Bootstrap values (>50 %) based on 1,000 545 
resamplings are shown. Filled circles: correspond also to nodes recovered in trees 546 
generated with the maximum-parsimony and maximum-likelihood algorithms. Open 547 
circles: correspond also to nodes recovered with either the maximum-parsimony or 548 
the maximum-likelihood algorithm. The sequence of Gloeobacter violaceus PCC 549 
7421 (GenBank accession no. AF132790) was used as an outgroup. Bar, 550 
0.1 substitutions per nucleotide position. 551 
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Supplementary figures 553 
 554 
Fig. S1. H2O2 production and antibacterial activities exhibited by strains Geitlerinema 555 
PCC 7105 (I) and Flo1 (II) documented by SDS-PAGE (A) and two different in-gel 556 
assay techniques (Panels B and C). Triplicate lanes loaded with identical non-heated 557 
samples were handled separately after gel electrophoresis. Panel A was stained with 558 
Coomassie brilliant blue, the two others were used for in-gel detection of the 559 
inhibitory substances using an H2O2 detecting assay (B) and an inhibitory plate test 560 
on LB agar with catalase negative mutant E. coli UM255 as target organism (C). 561 
M: molecular masses (kDa) of standard proteins (Spectra™ Multicolor Broad Range 562 
Protein Ladder; Fermentas). 563 
 564 
 565 
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L-Amino acid oxidases (L-amino acid: O2 oxidoreductase (deami-
nating), EC 1.4.3.2., L-AAO) are ﬂavoenzymes catalysing the oxidative
deamination of L-amino acids to the respective α-keto acids with the
release of ammonium and hydrogen peroxide (Wellner and Meister,
1961) which determines the antimicrobial property of L-AAOs (Stiles
et al., 1991). The enzyme is widely distributed in snake (Alves et al.,
2008;DuandClemetson, 2002) and insect venoms (Ahnet al., 2000) but
also in algal (Fujisawa et al., 1982), bacterial (Tong et al., 2008; Chen
et al., 2010a), cyanobacterial (Pistorius and Voss, 1980), fungal
(Kusakabe et al., 1980), gastropodal (Yang et al., 2005), and vertebratal
sources (Kasai et al., 2010; Sun et al., 2002). L-AAOs have been reported
as antitumor (Ahn et al., 2000; Kusakabe et al., 1980) as well as
bacteriostatic and bacteriocidal agents (Yang et al., 2005) and can be
differentiated in enzymeswith amore strict substrate speciﬁcity (Lucas-
Elío et al., 2006) and in those which have a broader spectrum (Gómez
et al., 2008). They typically have a dimeric structure. FAD is the cofactor
of L-AAOs and binds strongly but not covalently to the protein. A main
commercial application for L-AAOs is the production of D-amino acids
by enzymatic resolution of racemic amino acid solutions (Takahashi
et al., 1997; Parikh et al., 1958).
The aim of the present paper is to describe a new application of an
already published peroxidase-coupled assay for the detection of
hydrogen peroxide production by L-AAO activity. Chen et al. (2010b)
used this method spectrophotometrically to determine the substrate
speciﬁcity of an L-AAO produced by Pseudoalteromonas ﬂavipulchra
strain C2. In thepresent study,we used basically the sameassaymixture
for direct in-gel detection of L-amino acid oxidases after SDS-PAGE
based on the visualisation of occurring hydrogen peroxide production.
Sterile-ﬁltrated, 30× concentrated, possibly L-AAO-containing cul-
ture supernatant derived from a marine bacterium was mixed in a 4:1
(v/v) ratio with 4-fold concentrated sample buffer (0.25 M Tris–HCl, pH
6.8, 6% SDS, 20% ß-mercaptoethanol, 40% glycerol, and 0.04% bromo-
phenol blue). Concentrated samples were used in this study to even
detect very low amounts of possibly present L-AAOs. The samples were
placed in the polyacrylamide gel without heating (1 min at RT). The
stacking gel had an acrylamide concentration of 4% and the separation
gel of 10%, respectively. Protein separationwasperformedbySDS-PAGE,
as described by Laemmli (1970). Triplicate lanes were loaded with
identical samples and handled separately after PAGE. Two lanes were
stained with Coomassie brilliant blue (CBB) according to Kang et al.
(2002), the otherwaswashed three times for 5 minwithdistilledwater.
The non-stained lane aswell as oneof the Coomassie-stained laneswere
used for in-gel detections of the inhibitory substances using the assay
mixture described by Chen et al. (2010b) with some modiﬁcations.
Originally, the standard assaymixture in a 1 ml cuvette contained 500 μl
antibacterial protein solution, 60 mM Tris–HCl, pH 7.8, 5 mM L-amino
acid (one of the 20 standard amino acids), 400 mM 4-aminoantipyrine,
1 mMphenol, and 4 units of peroxidase (Sigma). The dye is produced by
peroxidase from hydrogen peroxide, 4-aminoantipyrine, and phenol.
Chen et al. (2010b) detected it spectrophotometrically at 505 nm. In the
present study, instead of a deﬁned amount of one of the standard amino
acids, a casamino acid solution (ﬁnal concentration 1%) was used as
amino acid source. Alternatively, a well-deﬁned mixture of the 20
standard amino acids (5 mM each) can also be used (data not shown).
Furthermore, no solution containing antibacterial compounds was
added. For direct in-gel detection of L-AAO activity, 2 ml of the enzyme
assay mixture was put on the appropriate gel lane. Using a scanner
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(Canon MX320), the formation of the dye was documented immedi-
ately over a period of 15–45 min in intervals of 2 min; depending on the
L-AAO concentration. Protein bands which produce H2O2 in the
presence of the assay mixture appear pale pink. Results are shown in
Fig. 1.
The L-AAOs used in the present study were resistant to SDS and ß-
mercaptoethanol, therefore, the SDS-PAGE could be performed under
non-denaturing conditions to maintain enzymatic activity and to
estimate the approximate molecular weight of these substances.
Considering the molecular weight standards (Page Ruler Prestained
Protein Ladder; Fermentas), the bands of H2O2 producing activity and
the corresponding Coomassie-stained protein bands on SDS-PAGEwere
present i) in the range between 55 and 70 kDa and ii) in the range larger
than 170 kDa in size (Fig. 1A, B and C). The L-AAOs still kept their
activity, even after having been exposed to the staining procedure with
CBB. Therefore, the assay mixture in one approach was directly used
with the Coomassie-stained gel to visualise H2O2 production (Fig. 1B). If
this is not the case, a non-stained lane should be incubated with the
assay mixture, and the result has to be compared with a Coomassie-
stained lane loaded with an identical sample to detect active L-AAOs
(Fig. 1C). When no activity is detected during non-denaturing SDS-
PAGE, the same experiments can be repeated by using native PAGE, but
without any information concerning the molecular weight of the
protein bands (data not shown). The visible smear of some bands is due
to the highly concentrated samples in combination with the sensitivity
of the used L-AAO detecting assay. To get sharply bounded bands, it
seems to be necessary to lower the concentration of L-AAOs in the
samples. Regarding the sensitivity of the H2O2 detecting assay mixture,
we found out that bands, unseen after staining with CBB according to
Kang et al. (2002), appearedwell visible after having a sufﬁcient contact
with the assay mixture (data not shown).
The results obtained in thepresent studyhave clearly shown that the
described in-gel L-AAO detecting application is simple, sensitive, rapid,
and reproducible. Therefore, many samples can be screened for L-AAO
presence in the course of a day. In addition, if a sample shows H2O2
producing activity when being in contact with the assay mixture, the
number and the approximate molecular weight of the L-AAOs can be
determined in one step as well, which are clear advantages in
comparison to common spectrophotometric L-AAO detecting methods.
Knowingdirectly numbers and approximatemolecularweights of the L-
AAOs can be very helpful for further puriﬁcation and characterisation of
this kind of enzymes.
Supplementarydata to this article canbe foundonline at doi: 10.1016/
j.mimet.2011.03.002.
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Fig. 1. SDS-PAGE and an in-gel assay technique for detecting H2O2 production. Triplicate
lanes loaded with identical non-heated samples were handled separately after gel
electrophoresis. Lanes A and B: stained with CBB. Lane B was additionally treated with an
H2O2 detecting assay mixture. Lane C: in-gel detection of the inhibitory substances using
the H2O2 detecting assay. M: molecular masses (kDa) of standard proteins (Page Ruler
Prestained Protein Ladder; Fermentas). A coloured version of the ﬁgure is accessible as
supplementary material (Supplementary Fig. S1, available in JMM Online).
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4. General discussion 
 
In this chapter, the main results obtained in the present study are discussed and 
compared with those reported for other Pseudoalteromonas and Geitlerinema 
species as well as some further distantly related organisms. Finally, some general 
conclusions are made and an outlook regarding promising continuative experiments 
is given.  
The purpose of this chapter should not be to repeat the results and discussion as 
well as conclusion parts from the manuscripts in detail, but to provide a more general 
and coherent overview about the achieved results, conclusions, and assumptions. 
 
4.1 Inhibitory substances from P. aurantia and P. citrea 
 
Several experiments were performed to characterise the inhibitory substances from 
P. aurantia and P. citrea concerning their properties as well as the growth conditions 
when they are produced (see Manuscript I, pages 33-61 and Manuscript II, pages 
62-88). 
 
It could be shown that P. aurantia and P. citrea are producing their inhibitory 
substances under standard incubation conditions during the late exponential to 
stationary growth phase, respectively (for details see Manuscript I, pages 44-45 and 
56-57, Figure 1 A and B). Similar results were reported by Chen and coworkers 
(2010b) for the Pseudoalteromonas species P. flavipulchra strain C2, which is 
producing its inhibitory protein at the beginning of the stationary growth phase. 
P. luteoviolacea strain 9K-V10 is also producing and secreting an antibacterial 
protein during the late exponential to stationary growth phase (McCarthy et al., 
1994). The Bifidobacterium strains RBL 68 and RBL 85 are starting to produce 
bacteriocin-like inhibitory substances in their late exponential growth phase and 
reached a maximum inhibitory activity during and after the stationary growth phase 
(Zouhir et al., 2011), whereas the antibacterial protein marinocine from Marinomonas 
mediterranea can first be detected at the death phase of growth (Lucas-Elío et al., 
2005). Bowman (2007) speculated that the time when the synthesis of inhibitory 
substances by Pseudoalteromonas species is starting, is triggered possibly by 
quorum sensing systems. This assumption is supported by several studies 
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concerning the role of quorum sensing in antibiotic compound production (El-Sayed 
et al., 2001; McGowan et al., 2005; Liu et al., 2007; Veselova et al., 2008; Duerkop 
et al., 2009). 
 
The results of the present study revealed that P. citrea is producing inhibitory 
substances when incubated at 10°C without shaking, whereas P. aurantia did not 
(for details see Manuscript I, pages 45-46 and 58-59, Figure 2 A and B). In contrast 
to that, Gauthier and Breitmayer (1979) found the production of inhibitory substances 
from P. aurantia not to be influenced by the incubation temperature. In addition, 
Gauthier (1977) reported that P. citrea formed higher levels of inhibitory substances 
at low temperatures, whereas the inhibitor production in the present study was not 
differing significantly in dependence of the incubation temperature. Only when 
P. citrea was grown by shaking at 150 rpm, the production was higher at 21 rather 
than at 26°C. The observed differences concerning the influence of the incubation 
temperature by Gauthier (1977), Gauthier and Breitmayer (1979), and the present 
study are possibly caused by the use of different growth media, artificial seawater in 
the present study, and marine broth (Difco) in that of both other studies mentioned 
before. Generally, the antibiotic production of bacteria often is strongly influenced by 
the incubation temperature (Paul and Banerjee, 1983; Larsen et al., 1993; Todorov 
et al., 1999). 
 
The present study has shown that the inhibitory activities of the inhibitors from both 
Pseudoalteromonas species are still detectable after contact with the enzymes 
-amylase and trypsin, whereas the activity is totally lost after exposure of the 
inhibitory substances to catalase, peroxidase as well as proteinase K (for details see 
Manuscript I, pages 46-47 and 55-56, Table 2). Since the conclusions from these 
findings were already described in detail in the mentioned manuscript, only the most 
important ones are discussed here, namely the influences of the last three 
mentioned enzymes. The neutralisation of the inhibitory activities by catalase and 
peroxidase leads to the assumption that hydrogen peroxide is involved in the 
mechanisms of inhibition, whereas the neutralising effect of proteinase K supports 
the concept of a proteinogenous nature for the inhibitory substances. The 
neutralising effect of catalase respectively the involvement of H2O2 in the inhibitory 
mechanism was reported previously not only for P. aurantia and P. citrea, but also 
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for other Pseudoalteromonads (Gauthier, 1977; Gauthier and Breittmayer, 1979; 
Gómez et al., 2008; Chen et al., 2010b). Interestingly, Gómez and coworkers (2008) 
as well as Chen and coworkers (2010b) found the inhibitory substances produced by 
different P. luteoviolacea strains respectively P. flavipulchra strain C2 to be L-AAOs 
and, therefore, are also of proteinogenous nature. Thereby, it has to be kept in mind 
that the activity of L-AAOs leads to the accumulation of H2O2. Thus, these findings in 
conclusion with the results from the present study gave the first hints that the 
inhibitory substances of P. aurantia and P. citrea could also be L-AAOs. Further 
details are discussed in the results and discussion part of Manuscript I (page 47). 
 
It could be shown that the inhibitory substances from both Pseudoalteromonads 
were thermolabile (those from P. citrea were more heat-sensitive than those from 
P. aurantia), but resistant against acid-alkaline treatment (for details see 
Manuscript I, pages 48-49 and 60-61, Figure 4 A and B). Other species of the genus 
Pseudoalteromonas are known also for the production of heat-sensitive 
proteinogenous inhibitory substances (Bowman, 2007). Thus, the presence of 
thermolabile inhibitory substances in P. aurantia and P. citrea is additionally 
supporting the assumption that both species are producing inhibitory proteins. The 
pH stability of the inhibitors produced by both Pseudoalteromonads is in accordance 
with the results from other studies dealing with members of this genus, which are 
also producing such substances more or less resistant to pH value variations 
(Gauthier and Breittmayer, 1979; Chen et al., 2010b). L-AAOs normally are also 
relatively heat-sensitive and resistant against acid-alkaline treatment (Piedras et al., 
1992; Arima et al., 2003; Yang et al., 2005; Chen et al., 2010b; Lee et al., 2011). 
Hence, the heat-sensitivity as well as the pH stability of the inhibitors from 
P. aurantia and P. citrea had also supported the idea that these substances are 
possibly L-AAOs, but at least proteins.  
These assumptions were additionally confirmed by the fact that isoelectric points of 
pH 8.7 (P. aurantia) respectively 8.9 and 9.4 (P. citrea) could be detected for the 
inhibitors from both species in the studies performed (for details see Manuscript I, 
pages 47-48 and 59, Figure 3 A and B). 
 
Regarding the antimicrobial potential of the inhibitory substances produced by 
P. aurantia and P. citrea, it could be shown by antibiogram studies that they strongly 
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inhibit the growth of MRSA, S. epidermidis and of several other bacterial strains. In 
the case of P. aurantia, the yeast S. pastorianus was inhibited, too (for details see 
Manuscript I, pages 42-43 and 55, Table 1). Other members of the genus 
Pseudoalteromonas are known also for the production of inhibitory substances active 
against MRSA and other clinical relevant strains. Some of these substances are of 
low molecular weight, but also high molecular weight substances, such as L-AAOs 
and other antibacterial proteins, are known (Bowman, 2007; Chen et al., 2010b). 
Interestingly, the inhibitory substances from P. aurantia and P. citrea had the 
strongest effect against the growth of the catalase negative mutant Escherichia coli 
UM255. This finding again showed that catalase and, thus, also hydrogen peroxide 
are playing an important role in the mechanism of inhibition and is supporting the 
assumption that the inhibitors from both Pseudoalteromonads are possibly L-AAOs. 
 
In addition, the antibiogram studies have indicated autoinhibition by P. aurantia and 
P. citrea, which is caused by the activity of their L-AAOs and the corresponding 
production of hydrogen peroxide (for details see Manuscript I, pages 42-43 and 55, 
Table 1). Holmström and coworkers (2002) also reported that P. citrea does inhibit 
its own growth, while P. rubra and P. tunicata exhibit only weak autoinhibitions, 
among 10 different Pseudoalteromonas species tested. Further studies have shown 
that the latter mentioned organism also produces an L-AAO, which could be 
identified as the autoinhibiting compound (Mai-Prochnow et al., 2006, 2008). Two 
P. luteoviolacea strains (Gómez et al., 2008) and P. flavipulchra (Chen et al., 2010b) 
were found to produce L-AAOs as well. Thus, due to the hydrogen peroxide 
producing activity of these enzymes, the latter mentioned organisms probably also 
inhibit their own growth, but this was not investigated so far. In addition, two other 
P. luteoviolacea strains are known for their production of autotoxic substances 
(Gauthier and Flatau, 1976; Sakata et al., 1986). With regard to the above 
mentioned findings from the present and also from other studies, it can be assumed 
that probably the substances from both P. luteoviolacea strains as well as the high 
molecular weight polyanionic substance with autotoxic property from P. rubra 
(Gauthier, 1976b) are L-AAOs as well. 
The influence of P. tunicata on the formation of biofilms and the ecological 
significance of its autotoxicity has been investigated in several studies (Mai-
Prochnow et al., 2004, 2006; Burmølle et al., 2006; Rao et al., 2010). The organism 
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was reported to exhibit a wide range of bioactive activities (Mai-Prochnow et al., 
2004; see also pages 130-132, Table 4.1), but, as already mentioned before, is also 
inhibiting its own growth. Mai-Prochnow and coworkers (2004) reported that 
AlpP, a 190 kDa L-AAO, is responsible for this autoinhibition. The same authors 
described the autotoxicity of AlpP as a mechanism similar to programmed cell death. 
Webb and coworkers (2003) previously described an equal mechanism during 
biofilm dispersal for Pseudomonas aeruginosa. In the case of P. tunicata, the 
process of programmed cell death due to L-AAO activity within substructures of the 
biofilm seems to provide nutrients for a subpopulation of cells, which is resistant to 
AlpP (Mai-Prochnow et al., 2004, 2008). As all Pseudoalteromonas cells, also the 
resistant ones are motile by swimming and it is therefore likely that they are 
dispersed in the surrounding environment. Thus, these survivors can recolonise new 
surfaces by again forming biofilms (Mai-Prochnow et al., 2004, 2006). Investigations 
on other bacteria lead to the assumption that programmed cell death due to the 
presence of antibiotic substances could be relatively common amongst biofilm 
forming organisms (Bayles, 2007). Hence, most probably also other autotoxic 
compound producing Pseudoalteromonas species, including P. aurantia and 
P. citrea, are showing the same effects on biofilm formation and dispersal. 
   
To finally prove the above mentioned assumption that the inhibitory substances from 
both Pseudoalteromonads are possibly L-AAOs, their presence was verified with a 
specific assay. L-AAOs can be detected using various spectrophotometric as well as 
fluorimetric methods. In all cases not the enzymes themselves, but the resulting 
products of the oxidative deamination of L-amino acid substrates by the activity of 
L-AAOs are detected. Some of these methods are indirectly measuring occurring 
hydrogen peroxide production i) by fluorimetric detection of H2O2-oxidised Amplex 
red (10-acteyl-3,7-dihydoxyphenoxazine) using a horseradish peroxidase-coupled 
assay (Palamakumbura and Trackman, 2002; Gómez et al., 2006), ii) by a 
spectrophotometric detection of a dye produced by peroxidase from H2O2, 
4-aminoantipyrine and phenol (Chen et al., 2010b) as well as iii) by a 
spectrophotometric detection of a dye produced by peroxidase from H2O2 and 
o-dianisidine (Geueke and Hummel, 2002). In another approach, specific for L-lysine 
oxidases, the production of the -keto acid formed is indirectly followed by the 
spectrometric measurement of the formation of a semicarbazone derivative obtained 
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by the reaction of semicarbazide with the -keto acid obtained after oxidative 
deamination of L-lysine (Danson et al., 2002). Furthermore, L-AAO activity can be 
spectrophotometrically determined by a coupled lactate dehydrogenase assay using 
different L-amino acids as substrates (Geueke and Hummel, 2002). The authors 
measured the formation of lactate produced by the enzyme from NADH and 
pyruvate. 
 
In the present study, the inhibitory substances from P. aurantia and P. citrea were 
identified using the spectrophotometric assay reported by Chen and coworkers 
(2010b). Applying this, it could be clearly shown that both Pseudoalteromonas 
species are producing amino acid oxidases (for details see Manuscript II, pages 
70-71 and 82-83, Figure 1). With the same assay also the substrate spectra of those 
enzymes were determined, revealing that the amino acid oxidases from both species 
can use several L-amino acids as substrates, but none of the tested D-amino acids. 
This led to the conclusion that both species are producing L-AAOs with broad 
substrate spectra. Among the members of the genus Pseudoalteromonas species 
are known to produce L-AAOs with low as well as with very high substrate 
specificities (Gomez et al., 2008; Mai-Prochnow et al., 2008; Chen et al., 2010b; see 
also chapter 1, page 24, Table 1.1).  
 
To get a rough idea of the number and molecular weights of the L-AAOs from 
P. aurantia and P. citrea, culture supernatants derived from both species were 
applied to a sequence of ultrafiltration runs and the resultant fractions were screened 
for inhibitory activity using agar diffusion tests (for details see Manuscript II, pages 
72 and 84, Figure 3 A and B). The results have shown that in the supernatant of P. 
aurantia inhibitory activity could be detected in three fractions (>100, >30 <50, and 
>50 <100 kDa in order of descending activities), but only in one of that from P. citrea 
(>100 kDa). In conclusion, P. aurantia is forming at least one inhibitory substance of 
30-100 kDa and one larger than 100 kDa, whereas P. citrea is producing at least one 
larger than 100 kDa. 
 
To determine the number and molecular weights of the L-AAOs produced by 
P. aurantia and P. citrea more precisely, the assay mixture for the 
spectrophotometric test used by Chen and coworkers (2010b) and in the present 
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study was directly applied to a polyacrylamid gel, loaded with samples possibly 
containing L-AAOs, both after native PAGE and non-denaturing SDS-PAGE (for 
details concerning the method see Manuscript IV, pages 117-118). The described in-
gel L-AAO detecting approach was found to be simple, sensitive, rapid, and 
reproducible. In comparison to common spectrophotometric or fluorimetric methods 
the clear advantages of this new technique are not only the validation of L-AAO 
presence in a sample, but also the determination of their number and approximate 
molecular weights. Non-denaturing SDS-PAGE could be used due to the finding that 
the activity of the inhibitory substances produced by P. aurantia and P. citrea had 
shown to be relatively resistant to SDS and ß-mercaptoethanol (for details see 
Manuscript II, pages 71-72 and 83-84, Figure 2 A and B). 
 
Using the new approach, it could be determined that P. aurantia most probably 
produces three L-AAOs of 60-65, 225-230, and >260 kDa in size, whereas P. citrea 
forms two, with molecular masses of 165-170 and 225-230 kDa (for details see 
Manuscript II, pages 72-73 and 85, Figure 4 A and B). P. aurantia was first described 
by Gauthier and Breittmayer (1979), who reported the presence of only one 
polyanionic inhibitory substance, whereas Gauthier (1977) found 2 different 
polyanionic inhibitory substances for P. citrea. Other members of the genus 
Pseudoalteromonas are known also for the production of high molecular weight 
L-AAOs (Gomez et al., 2008; Mai-Prochnow et al., 2008; Chen et al., 2010b; see 
also chapter 1, page 24, Table 1.1). 
 
Size exclusion chromatography (SEC) via fast protein liquid chromatography (FPLC) 
was also used to analyse the L-AAOs produced by both Pseudoalteromonas species 
studied. The resulting fractions were screened for inhibitory activity showing that 
P. aurantia produces 3 L-AAOs of approximately 100, 240, and 480 kDa in size, 
whereas P.citrea forms only one of approximately 120 kDa (for details see 
Manuscript II, pages 73-74). Concerning P. aurantia, these findings are mainly in 
accordance with the results obtained in the SDS-PAGE study (see above), but, 
regarding P. citrea, there is a discrepancy in the number of L-AAOs (one instead of 
two; see above). The facts which might explain the differences between the findings 
from the SDS-PAGE and SEC studies as well as those obtained by Gauthier (1977) 
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and by Gauthier and Breittmayer (1979) are discussed in detail in the Manuscript II 
(page 74). 
In the present study, various hints could be found that the three L-AAOs from 
P. aurantia might be all composed of one structural unit of 60-65 kDa in size. In this 
context, the 225-230 kDa L-AAO might be a tetramer of this small unit, whereas the 
L-AAO >260 kDa, respectively 480 kDa with regard to the results obtained by the 
SEC study, is possibly the corresponding octamer. These assumptions are 
supported by several other findings from the present study and by those reported by 
other authors and are discussed comprehensively in Manuscript II (pages 74-76). 
 
4.2 Inhibitory substance from Geitlerinema strain Flo1 
 
The filamentous cyanobacterial strain Flo1 was investigated regarding its taxonomic 
position amongst closely related organisms. In addition, an inhibitory substance 
produced by this strain was identified and characterised (see Manuscript III, pages 
89-115). 
 
By using the basic local alignment search tool (BLAST) at GenBank and by 
re-constructing phylogenetic trees with the nearly complete 16S rDNA sequence 
(1,348 bp) of strain Flo1 and those of closely related strains, it could be revealed that 
Flo1 is clustering amongst species from the genus Geitlerinema. The morphological 
and physiological characteristics of the strain (e.g. filamentous, unsheated, 
non-heterocystous, mostly bright blue-green with cylindrical, straight trichomes which 
are motile by gliding) also fit to those of other members of this genus. Thus, the 
affiliation of strain Flo1 to the genus Geitlerinema could be unambiguously clarified 
(for details see Manuscript III, pages 103 and 113-114, Figure 3 as well as chapter 6, 
pages 158-159, Figures S4 and S5).  
 
The antimicrobial potential of culture supernatants from strain Flo1 and from the 
reference strain Geitlerinema PCC 7105 was determined by using agar diffusion 
tests. Thus, it could be shown that the culture supernatant of strain Flo1 had 
inhibitory activity against several heterotrophic bacteria, including the clinical relevant 
strain S. epidermidis, whereas the growth of the tested yeast was not affected. In 
contrast to that, the culture supernatant of strain PCC 7105 exhibited no inhibitory 
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activity against any of the organisms tested (for details see Manuscript III, pages 98 
and 111, Table 1). These results lead to the conclusion that strain Flo1 is producing 
at least one inhibitory substance with antibacterial activity, but strain PCC 7105 does 
not. By taking a closer look at the inhibition pattern of the substance from Flo1, 
noticeable similarities with the results from the antibiogram studies performed with P. 
aurantia and P. citrea could be observed. In all cases growth of B. subtilis was not 
inhibited and that of the yeast S. pastorianus only partially by the supernatant from 
P. aurantia. The growth of E. coli K12, P. fluorescens, S. epidermidis, and E. coli 
UM255 was inhibited in all cases, whereas the catalase-negative mutant E. coli 
UM255 was affected most (for details see Manuscripts I, page 55, Table 1 and 
Manuscript III, page 111, Table 1). Heyduck-Söller and Fischer (2000) as well as 
Caicedo and coworkers (2010) also investigated the antimicrobial potential of culture 
supernatants from strain Flo1 and found, in some respects, contrary results. These 
findings in detail and possible reasons for the differences are broadly discussed in 
Manuscript III (pages 98-100).    
The above mentioned inhibition pattern similarities have led to the assumption that 
the inhibitory potential of the culture supernatant derived from strain Flo1 is possibly 
due to an L-AAO presence, as could be verified for both Pseudoalteromonas species 
(for details see Manuscript II, page 70 and chapter 4.1, page 124). 
 
To clarify this possibility, the same spectrophotometric approach (Chen et al., 
2010b), used to identify the inhibitory substances from P. aurantia and P. citrea, was 
performed (compare chapter 4.1, pages 123-124). Thus, it could be clearly shown 
that strain Flo1 is producing an amino acid oxidase, in particular, a specific L-lysine 
oxidase (for details see Manuscript III, pages 100-101 and 111-112, Figure 1). Other 
cyanobacterial species have also been reported to produce L-AAOs. Accordingly, 
Gau and coworkers (2007) mentioned that different Synechococcus strains are 
producing L-AAOs specific for basic L-amino acids, but, to my knowledge, a specific 
L-lysine oxidase was not described so far. Therefore, the finding from the present 
study can be regarded as a novum concerning cyanobacteria. 
 
Using the newly described in-gel L-AAO detecting technique (see Manuscript IV, 
pages 117-118 and chapter 4.1, pages 124-125), it could be shown that strain Flo1 
is producing one L-AAO of approximately 55 kDa in size, whereas PCC 7105 does 
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not produce any substance of this kind (for details see Manuscript III, pages 101-102 
and 112-113, Figure 2). Gau and coworkers (2007) analysed putative L-AAOs in 
different cyanobacteria by evaluating 24 genomes for the presence of the aoxA gene 
encoding a protein with L-AAO similarity. The authors reported that in members of 
several cyanobacterial genera this gene is detectable, including Gloeobacter, 
Nostoc, Synechococcus, Synechocystis as well as Trichodesmium species. In 
addition, the same authors evaluated possible molecular weights of mainly 
51-54 kDa for the putative L-AAOs. Hence, these results are in accordance with the 
finding from the present study of a 55 kDa L-AAO produced by strain Flo1. 
Schriek and coworkers (2009) reported that Synechocystis sp. PCC 6803 is 
producing an L-amino acid dehydrogenase of approximately 404 kDa in size, called 
Slr0782. In comparison to L-AAOs, the dehydrogenase is not causing H2O2 
production by its activity and, thus, has no inhibitory effects. Apart from that, the 
authors found out that Slr0782 is functioning as an L-arginine dehydrogenase which 
is mediating the electron transfer from L-arginine into the respiratory electron 
transport chain utilizing oxygen as electron acceptor via cytochrome oxidase. The 
same authors concluded that Slr0782 is acting as an additional substrate 
dehydrogenase being able to interact with the electron transport chain of the 
thylakoid membrane of strain PCC 6803.  
 
If and, when, to what extent cyanobacterial produced L-AAOs, like the one from 
Geitlerinema strain Flo1, are playing a role in the pathogenicity of the BBD (compare 
chapter 1.2.2, pages 21-22) is not known so far, but it can be speculated that they 
probably have influences in this regard. 
 
4.3 Bioactive substances from Pseudoalteromonas and Geitlerinema species: 
an overview 
 
Species from the genera Pseudoalteromonas and Geitlerinema are known for the 
production of various bioactive substances with diverse activities, including L-AAOs. 
P. aurantia strain NCIMB 2052T, P. citrea strain NCIMB 1889T, and Geitlerinema 
strain Flo1, as could be shown in the present study, are also producing this type of 
bioactive substances with inhibitory activity.  
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To provide a comprehensive overview about the different producers and their 
associated substances, corresponding findings concerning Pseudoalteromonas and 
Geitlerinema species are summarised in Table 4.1 (pages 130-132). 
 
Interestingly, the genus Pseudoalteromonas can be relatively accurately 
taxonomically separated into pigmented and non-pigmented species clades 
(Bowman, 2007; see also chapter 6, page 157, Figure S3). Accordingly, Egan and 
coworkers (2002) found that pigmentation is linked with the ability of P. tunicata to 
produce its bioactive natural products. Previous studies of Holmström and coworkers 
(1996) as well as of Holmström and Kjelleberg (1999) confirmed this finding also for 
other members of the genus. Several other pigmented Pseudoalteromonads are also 
known to produce bioactive compounds (Gauthier, 1976; Holmström et al., 1998; 
Egan et al., 2001; Ivanova et al., 2002a; Isnansetyo and Kamei, 2003a,b; Gómez 
et al., 2008; Chen et al., 2010b etc.), whereas non-pigmented do not seem to have 
the same extensiveness of synthesis of this kind of substances (Bowman, 2007; see 
also Table 4.1, pages 130-132). The two Pseudoalteromonas species P. aurantia 
and P. citrea, investigated during the present study, are also pigmented and are 
producing bioactive compounds. 
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Tab. 4.1 Sources, pigmentation, and bioactive substances as well as their properties of 
members from the genera Pseudoalteromonas and Geitlerinema. Species and results from 
the present study are in bold type. 
 
Species 
 
Source Pigmentation Bioactive substance Property 
 
P. agarivorans 1 
 
ascidians, sea water 
 
- 
 
- 
 
degrades algal 
polysaccharides 
P. aliena 2 sea water + (melanin) unknown compound(s) anti-tumour 
P. antarctica 3,4 
 
muddy soils, sea-ice, 
sea water, sediment 
- unknown compound(s) antibacterial; novel 
polysaccharides, cold-
active enzymes 
P. arctica 5 arctic sea water + (slightly orange) - pullulanase, pectinase 
P. atlantica 6 surface of 
macroalgae, sea 
water  
+ (beige to pale 
yellow orange) 
- degrades algal 
polysaccharides 
P. aurantia 7-9 sea water, surface of 
Ulva lactuca 
+ (yellow to 
orange) 
L-AAO(s); possibly 
other unknown 
compounds 
antibacterial; anti-
fungal; inhibits 
settlement of 
invertebrate larvae; 
inhibits algal spore 
settlement 
P. byunsanensis 10 tidal flat sediment + (purple) - gelatinase 
P. carrageenovora 6 surface of 
macroalgae, sea 
water 
+ (beige to pale 
yellow orange) 
- degrades algal 
polysaccharides 
P. citrea 4,7,9,11,12 
 
ascidians, mussels, 
sea water, sponges 
+ (yellow) L-AAO(s);  
possibly other 
unknown compounds 
antibacterial; inhibits 
settlement of 
invertebrate 
larvae; cytotoxic 
against sea urchin; 
degrades algal 
polysaccharides 
P. denitrificans 13-19 
 
 
sea water + (red) cycloprodigiosin HCl anti-malarial; anti-
tumour; inhibits 
T cell/lymphocyte 
proliferation; induces 
settlement of sea 
urchin 
P. distincta 20 sponge ± (melanin) - - 
P. donghaensis 21 sea water - - - 
P. elyakovii 22,23 macroalga, mussels  - - - 
P. espejiana 24 sea water - - - 
P. flavipulchra 25,26 coral, sea water  + (yellow to 
orange) 
L-AAO antibacterial 
P. haloplanktis 27-30 sea water - novel 
diketopiperazines 
cold-active enzymes; 
probiotic benefits to 
shellfish 
P. issachenkonii 4,31 
 
marine alga - isatin; unknown 
reddish brown 
compound 
antibacterial; anti-
fungal; hemolytic 
P. lipolytica 32 sea water - - lipolytic 
P. luteoviolacea 4,9,19,33-36 
 
marine alga, 
seawater 
+ (purple, yellow) L-AAO; low and high 
molecular weight 
inhibitory substances, 
including pyrrole-
containing compounds 
antimicrobial; anti-
algal; anti-fungal; 
inhibits algal spore 
settlement; inhibits 
settlement of 
invertebrate 
larvae; cytotoxic 
against sea urchin; 
induces settlement of 
sea urchin 
P. maricaloris 25,37 sponges + (yellow) dibromo- and 
bromoaltero-chomides 
antimicrobial; cytotoxic 
against sea urchin 
P. marina 38 tidal flat sediment + (pale yellow) - - 
P. mariniglutinosa 39 diatoms - - - 
P. nigrifaciens 40,41 mussels, salted 
foods, sea water 
± (melanin) - - 
P. paragorgicola 42 sponge - - - 
P. peptidolytica 4,43 sea water + (yellow) unknown compound(s) antibacterial; 
hemolytic 
P. phenolica 44,45 sea water + (brown) brominated biphenyl 
compound (MC21-A) 
antibacterial 
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P. piscicida 4,9,46-49 estuarine waters, 
fish 
+ (yellow) toxic protein; unknown 
anti-algal compounds 
antimicrobial; anti-algal 
P. prydzensis 50 sea ice - - - 
P. rubra 9,14-18,51-54 sea water + (red) high molecular weight 
polyanionic substance; 
cycloprodigiosin HCl; 
rubrenoic acids 
antibacterial; anti-
algal; anti-fungal; anti-
malarial; anti-tumour; 
bronchodilatatoric; 
inhibits 
T cell/lymphocyte 
proliferation; inhibits 
settlement of 
invertebrate 
larvae; inhibits algal 
spore settlement 
P. ruthenica 4,55-57 mussels, saltern, 
sea water 
+ (pale orange) unknown compound(s) antibacterial; hemolytic 
P. spongiae 58,59 sponge + (pale orange) unknown compound(s) induces settlement of 
invertebrate 
larvae 
P. tetraodonis 60,61 puffer fish - tetrodotoxin neurotoxic effects 
P. translucida 42 sea water - - - 
P. tunicata 9,62-67 marine algae, 
tunicates 
+ (dark-green, 
purple, white, 
yellow) 
unknown purple 
pigment; tambjamine-
like alkaloid (YP1); 
toxic protein AlpP  
(L-AAO); unknown 
compound(s) 
antibacterial; anti-
fungal; anti-algal; 
inhibits settlement of 
invertebrate 
larvae; inhibits algal 
spore settlement; 
inhibits protists   
P. ulvae 9,64,68 marine alga + (dark-purple) unknown dark-purple 
pigment; unknown 
compound(s) 
antibacterial; inhibits 
settlement of 
invertebrate 
larvae and algal 
spores; inhibits algal 
spore germination 
P. undina 4,9,24,29,30 fish, sea water - unknown compound(s) antibacterial; 
hemolytic; probiotic 
benefits; possible 
opportunistic fish 
pathogen 
     
Geitlerinema BBD strains 69-
71 
microbial mats on 
corals 
+ (blue-green) microcystins induces coral tissue 
lysis and death 
Geitlerinema cf. sp. 72 sea water + (blue-green) yellow cytotoxic linear 
lipopeptide 
(mitsoamide) 
anti-tumour; toxic 
against brine shrimp 
Geitlerinema strain Flo1 
7,73,74 
sea water 
(mangrove wood) 
+ (blue-green) L-AAO; possibly other 
unknown compounds 
antibacterial; 
antimicrobial 
G. splendidum 75 freshwater + (blue-green) microcystins antimicrobial; anti-
algal; induces 
morphological and 
ultrastructural 
alterations of 
cyanobacteria and 
microalgae 
 
+ = present; - = not present or not determined; 1 Romanenko et al., 2003a; 2 Ivanova et al., 
2004; 3 Bozal et al., 1997; 4 Kalinovskaya et al., 2004; 5 Al Khudary et al., 2008; 6 Akagawa-
Matsushita et al., 1992; 7 data from the present study; 8 Gauthier and Breittmayer, 1979; 
9 Holmström et al., 2002; 10 Park et al., 2005; 11 Gauthier, 1977; 12 Urvantseva et al., 2006; 
13 Enger et al., 1987; 14 Magae et al., 1996; 15 Kawauchi et al., 1997; 16 Kim et al., 1999; 
17 Campàs et al., 2003; 18 Pérez-Tomás et al., 2003; 19 Huggett et al., 2006; 20 Romanenko 
et al., 1995; 21 Oh et al., 2011; 22 Ivanova et al., 1996a; 23 Sawabe et al., 2000; 24 Chan et al., 
1978; 25 Ivanova et al., 2002a; 26 Chen et al., 2010b; 27 Baumann et al., 1972; 28 Mitova et al., 
2005; 29 Riquelme et al., 1996; 30 Maeda et al., 1997; 31 Ivanova et al., 2002b; 32 Xu et al., 
2010; 33 Gauthier and Flatau, 1976; 34 Kamei et al., 1986; 35 Bowman, 2007; 36 Gómez et al., 
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2008; 37 Sobolevskaya et al., 2005; 38 Nam et al., 2007; 39 Romanenko et al., 2003b; 
40 Baumann et al., 1984; 41 Ivanova et al., 1996b; 42 Ivanova et al., 2002c; 43 Venkateswaran 
and Dohmoto, 2000; 44 Isnansetyo and Kamei, 2003a; 45 Isnansetyo and Kamei, 2003b; 
46 Bein, 1954; 47 Meyers et al., 1959; 48 Hansen et al., 1965; 49 Buck and Meyers, 1966; 
50 Bowman, 1998; 51 Gauthier, 1976a; 52 Gauthier, 1976b; 53 Gerber and Gauthier, 1979; 
54 Bowman, 2007; 55 Ivanova et al., 2002d; 56 Saravanan et al., 2006; 57 Sánchez-Porro et al., 
2009; 58 Lau et al., 2005; 59 Huang et al., 2007; 60 Simidu et al., 1990; 61 Ivanova et al., 2001; 
62 Holmström et al., 1998; 63 Franks et al., 2005; 64 Egan et al., 2000; 65 Egan et al., 2002; 
66 James et al., 1996; 67 Mai-Prochnow et al., 2008; 68 Egan et al., 2001; 69 Richardson et al., 
2007; 70 Gantar et al., 2009; 71 Stani et al., 2011; 72 Andrianasolo et al., 2007; 73 Heyduck-
Söller and Fischer, 2000; 74 Caicedo et al., 2010; 75 Valdor and Aboal, 2007  
 
4.4 Conclusions 
 
Taking advantage of the broad-spectrum antibacterial activity of the L-AAOs 
investigated in the present study and, in the case of the Pseudoalteromonas 
L-AAOs, their alkaline stability, these enzymes could possibly be used as antibiotics 
in medical therapy. Although, L-AAOs in general are reported to exhibit some toxic 
activities (Samel et al., 2008), it has been also shown that this kind of enzymes have 
only very low lethal toxicity in mice (Tan and Fung, 2010). Ciscotto and coworkers 
(2009) described a so-called “bactericidal window” where concentrations of hydrogen 
peroxide and other reactive oxygen species sufficient to inhibit bacterial growth are 
no thread to the host (human) cells. Sorg (2004) also pointed out that 
microorganisms are normally more sensitive to reactive oxygen species than human 
tissues. But, due to the proteinaceous nature of L-AAOs and relatively high 
production costs, the application of these enzymes in medical therapy as antibiotic 
agents will probably always be limited. Anyhow, further investigations with respect to 
the principles of L-AAO activities possibly will contribute to the development of new 
pharmaceutical compounds or to the implementation of novel therapeutic 
applications. 
Regarding the functions of the L-AAOs in the Pseudoalteromonas and Geitlerinema 
species investigated in the present study, it only can be speculated. It would be 
possible that they play a role in the utilization of L-amino acids as a nitrogen source. 
Furthermore, it is likely that they display defence and/or pathogenic functions. In 
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addition, it would be conceivable that the produced L-AAOs are influencing the 
formation and the dispersal of microbial biofilms. 
 
4.5 Outlook 
 
In the present study the inhibitory substances from P. aurantia and P. citrea were 
characterised concerning various aspects. In addition, also a substance with 
inhibitory activity produced by Geitlerinema strain Flo1 was investigated. Although, in 
all cases the substances could be identified, several questions could not be 
answered so far. 
Hence, it would be interesting to investigate the effects of different growth 
parameters, e.g. pH, temperature (a broader range than already determined), supply 
of nutrients, salts, trace elements, and vitamins on the respective L-AAO production 
rates.  
Furthermore, only the antimicrobial potential of the examined L-AAOs was evaluated 
in the present study. Thus, little to nothing is known, what kind of effects these 
enzymes from P. aurantia, P. citrea, and from the cyanobacterial strain Flo1 have 
upon algae, blood components (platelets), cells (including cancer cells), 
dinoflagellates, fungi, and viruses. In addition, it would be interesting to further 
investigate, if the L-AAOs are able to inhibit the settlement of invertebrate larvae and 
algal spores (from other species than already reported). 
Additionally, it could be investigated, what kind of physiological roles the L-AAOs 
have in their producers and in interaction with the environment. In this respects, the 
influences of L-AAOs during biofilm formation would be of special interest.  
Another promising approach would be the search for new biotechnological 
applications for L-AAOs. Accordingly, it would be desirable to determine the amino 
acid sequences of the investigated L-AAOs, for instance using matrix-assisted 
laser desorption ionization-time-of-flight/time-of-flight (MALDI-TOF/TOF) mass 
spectrometry top-down sequence analysis. Another step could be the cloning of the 
respective L-AAO encoding genes into an appropriate microorganism, e.g. into 
E. coli or into a yeast, to produce the L-AAOs on large scale. 
Last but not least, further Pseudoalteromonas and Geitlerinema species as well as 
those from other promising genera could be spectrophotometrically screened for the 
presence of L-AAOs and the newly developed in-gel L-AAO detecting approach 
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could be used to determine their number and approximate molecular weights. 
Promising Pseudoalteromonas candidates could be P. aliena, P. antarctica, 
P. issachenkonii, P. peptidolytica, P. piscicida, P. rubra, P. ruthenica, P. spongiae, 
P. ulvae, and P. undina, due to the presence of so far unidentified bioactive 
substances. 
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